Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Table of Contents

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

__________________________

FORM 10-Q

__________________________

(Mark One)


☒			QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended: March 31, 2024


☐			TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from to

Commission File Number: 0-19254

__________________________

LIFETIME BRANDS, INC.

(Exact name of registrant as specified in its charter)

__________________________


Delaware			11-2682486
(State or other jurisdiction of incorporation or organization)			(I.R.S. Employer Identification No.)

1000 Stewart Avenue, Garden City, New York 11530

(Address of principal executive offices) (Zip Code)

(516) 683-6000

(Registrant’s telephone number, including area code)

__________________________

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading
Symbol(s)

Name of each exchange
on which registered

Common Stock, $.01 par value

LCUT

The Nasdaq Global Select Market

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer

☐

Accelerated filer

☒

Non-accelerated filer

☐

Smaller reporting company

☒

Emerging growth company

☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

The number of shares of the registrant’s common stock outstanding as of April 30, 2024 was 22,073,256.

Table of Contents

LIFETIME BRANDS, INC.

FORM 10-Q

FOR THE QUARTER ENDED MARCH 31, 2024

INDEX


		Page No.

Part I.	Financial Information

Item 1.	Financial Statements

	Condensed Consolidated Balance Sheets – March 31, 2024 (unaudited) and December 31, 2023	2

	Condensed Consolidated Statements of Operations (unaudited) – Three Months Ended March 31, 2024 and 2023	3

	Condensed Consolidated Statements of Comprehensive Loss (unaudited) – Three Months Ended March 31, 2024 and 2023	4

	Condensed Consolidated Statements of Stockholders’ Equity (unaudited) –Three Months Ended March 31, 2024 and 2023	5

	Condensed Consolidated Statements of Cash Flows (unaudited) – Three Months Ended March 31, 2024 and 2023	6

	Notes to Condensed Consolidated Financial Statements (unaudited)	7

Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	29

Item 3.	Quantitative and Qualitative Disclosures About Market Risk	39

Item 4.	Controls and Procedures	39

Part II.	Other Information

Item 1.	Legal Proceedings	39

Item 1A.	Risk Factors	39




Item 5.	Other Information	40

Item 6.	Exhibits	41

Signatures		42

Table of Contents

PART I. FINANCIAL INFORMATION

Item 1. Financial Statements

LIFETIME BRANDS, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

(in thousands, except share data)


	March 31, 2024		December 31, 2023
	(unaudited)
ASSETS
CURRENT ASSETS
Cash and cash equivalents	$	4,639	$	16,189
Accounts receivable, less allowances of $15,177 at March 31, 2024 and $15,952 at December 31, 2023	113,645		155,180
Inventory	189,820		188,647
Prepaid expenses and other current assets	13,915		16,339

TOTAL CURRENT ASSETS	322,019		376,355
PROPERTY AND EQUIPMENT, net	16,356		16,970
OPERATING LEASE RIGHT-OF-USE ASSETS	66,662		69,756
INVESTMENTS	—		1,826
INTANGIBLE ASSETS, net	195,343		199,133
OTHER ASSETS	2,286		3,102

TOTAL ASSETS	$	602,666	$	667,142
LIABILITIES AND STOCKHOLDERS’ EQUITY
CURRENT LIABILITIES
Current maturity of term loan	$	10,652	$	4,742


Accounts payable	32,855		54,154
Accrued expenses	64,697		78,356
Income taxes payable	567		641
Current portion of operating lease liabilities	14,251		14,075
TOTAL CURRENT LIABILITIES	123,022		151,968
OTHER LONG-TERM LIABILITIES	9,257		9,126
INCOME TAXES PAYABLE, LONG-TERM	1,493		1,493
OPERATING LEASE LIABILITIES	66,278		70,009
DEFERRED INCOME TAXES	7,429		7,438
REVOLVING CREDIT FACILITY	40,860		60,395
TERM LOAN	130,626		135,834
STOCKHOLDERS’ EQUITY
Preferred stock, $1.00 par value, shares authorized: 100 shares of Series A and 2,000,000 shares of Series B; none issued and outstanding	—		—
Common stock, $0.01 par value, shares authorized: 50,000,000 at March 31, 2024 and December 31, 2023; shares issued and outstanding: 22,073,256 at March 31, 2024 and 21,813,266 at December 31, 2023	221		218
Paid-in capital	277,496		277,728
Accumulated deficit	(20,771)		(13,568)
Accumulated other comprehensive loss	(33,245)		(33,499)
TOTAL STOCKHOLDERS’ EQUITY	223,701		230,879
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY	$	602,666	$	667,142

See accompanying notes to unaudited condensed consolidated financial statements.

- 2 -

Table of Contents

LIFETIME BRANDS, INC.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(in thousands, except per share data)

(unaudited)


	Three Months Ended March 31,
	2024		2023
Net sales	$	142,242	$	145,435
Cost of sales	84,695		91,593
Gross margin	57,547		53,842
Distribution expenses	16,181		16,885
Selling, general and administrative expenses	39,536		37,907
Restructuring expenses	—		856

Income (loss) from operations	1,830		(1,806)
Interest expense	(5,614)		(5,336)
Mark to market loss on interest rate derivatives	(174)		(234)

Loss before income taxes and equity in losses	(3,958)		(7,376)
Income tax (provision) benefit	(210)		1,348
Equity in losses, net of taxes	(2,092)		(2,777)
NET LOSS	$	(6,260)	$	(8,805)
BASIC LOSS PER COMMON SHARE	$	(0.29)	$	(0.41)
DILUTED LOSS PER COMMON SHARE	$	(0.29)	$	(0.41)

See accompanying notes to unaudited condensed consolidated financial statements.

- 3 -

Table of Contents

LIFETIME BRANDS, INC.

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS

(in thousands)

(unaudited)


	Three Months Ended March 31,
	2024		2023
Net loss	$	(6,260)	$	(8,805)
Other comprehensive income, net of taxes:
Translation adjustment	40		1,561
Net change in cash flow hedges	201		(1,153)
Effect of retirement benefit obligations	13		12
Other comprehensive income, net of taxes	254		420
Comprehensive loss	$	(6,006)	$	(8,385)

See accompanying notes to unaudited condensed consolidated financial statements.

- 4 -

Table of Contents

LIFETIME BRANDS, INC.

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY

(in thousands)

(unaudited)


	Common stock			Paid-in capital		Accumulated deficit		Accumulated other comprehensive loss		Total
	Shares	Amount
BALANCE AT DECEMBER 31, 2023	21,813	$	218	$	277,728	$	(13,568)	$	(33,499)	$	230,879

Net loss	—	—		—		(6,260)		—		(6,260)



Other comprehensive income, net of taxes	—	—		—		—		254		254
Performance shares issued to employees	152	2		(2)		—		—		—
Net issuance of restricted shares granted to employees	213	2		(2)		—		—		—
Stock compensation expense	—	—		799		—		—		799


Shares effectively repurchased for required employee withholding taxes	(105)	(1)		(1,027)		—		—		(1,028)

Dividends (1)	—	—		—		(943)		—		(943)
BALANCE AT MARCH 31, 2024	22,073	$	221	$	277,496	$	(20,771)	$	(33,245)	$	223,701


	Common stock			Paid-in capital		Retained earnings (accumulated deficit)		Accumulated other comprehensive loss		Total
	Shares	Amount
BALANCE AT DECEMBER 31, 2022	21,780	$	218	$	274,579	$	1,145	$	(35,854)	$	240,088

Net loss	—	—		—		(8,805)		—		(8,805)



Other comprehensive income, net of taxes	—	—		—		—		420		420

Performance shares issued to employees	120	1		(1)		—		—		—
Net issuance of restricted shares granted to employees	185	2		(2)		—		—		—
Stock compensation expense	—	—		866		—		—		866

Shares effectively repurchased for required employee withholding taxes	(74)	(1)		(438)		—		—		(439)
Stock repurchase	(320)	(3)		—		(2,536)		—		(2,539)
Dividends (1)	—	—		—		(930)		—		(930)
BALANCE AT MARCH 31, 2023	21,691	$	217	$	275,004	$	(11,126)	$	(35,434)	$	228,661

(1) Cash dividends declared per share of common stock were $0.0425 and $0.0425 in the three months ended March 31, 2024 and 2023, respectively.

See accompanying notes to unaudited condensed consolidated financial statements.

- 5 -

Table of Contents

LIFETIME BRANDS, INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(in thousands) (unaudited)


	Three Months Ended March 31,
	2024		2023
OPERATING ACTIVITIES
Net loss	$	(6,260)	$	(8,805)
Adjustments to reconcile net loss to net cash provided by operating activities:
Depreciation and amortization	4,939		4,870

Amortization of financing costs	739		477
Mark to market loss on interest rate derivatives	174		234
Non-cash lease adjustment	(455)		(713)
Provision for doubtful accounts	195		1,643

Stock compensation expense	807		861
Undistributed losses from equity investment, net of taxes	2,092		2,777




Changes in operating assets and liabilities
Accounts receivable	41,119		15,336
Inventory	(1,566)		13,368
Prepaid expenses, other current assets and other assets	3,159		1,811
Accounts payable, accrued expenses and other liabilities	(34,359)		(18,085)
Income taxes receivable	—		(1,434)
Income taxes payable	(71)		(235)

NET CASH PROVIDED BY OPERATING ACTIVITIES	10,513		12,105
INVESTING ACTIVITIES
Purchases of property and equipment	(600)		(511)



NET CASH USED IN INVESTING ACTIVITIES	(600)		(511)
FINANCING ACTIVITIES
Proceeds from revolving credit facility	51,484		18,357
Repayments of revolving credit facility	(70,822)		(8,680)





Payments for finance lease obligations	(7)		(7)
Payments of tax withholding for stock based compensation	(1,028)		(439)

Payments for stock repurchase	—		(2,539)
Cash dividends paid	(1,026)		(985)

NET CASH (USED IN) PROVIDED BY FINANCING ACTIVITIES	(21,399)		5,707
Effect of foreign exchange on cash	(64)		59
(DECREASE) INCREASE IN CASH AND CASH EQUIVALENTS	(11,550)		17,360
Cash and cash equivalents at beginning of period	16,189		23,598
CASH AND CASH EQUIVALENTS AT END OF PERIOD	$	4,639	$	40,958

See accompanying notes to unaudited condensed consolidated financial statements.

- 6 -

LIFETIME BRANDS, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

March 31, 2024

(unaudited)

NOTE 1 — BASIS OF PRESENTATION AND SUMMARY OF ACCOUNTING POLICIES

Organization and business

Lifetime Brands, Inc. (“the Company”) designs, sources and sells branded kitchenware, tableware and other products used in the home and markets its products under a number of widely-recognized brand names and trademarks, which are either owned or licensed by the Company or through retailers’ private labels and their licensed brands. The Company’s products, which are targeted primarily towards consumers purchasing moderately priced kitchenware, tableware and housewares, are sold through virtually every major level of trade. The Company generally markets several lines within each of its product categories under more than one brand. The Company sells its products directly to retailers (who may resell the Company’s products through their websites) and, to a lesser extent, to distributors. The Company also sells a limited selection of its products directly to consumers through its own websites.

Basis of presentation

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles (“U.S. GAAP”) for interim financial information and with the instructions to Quarterly Reports on Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements. In the opinion of management, all adjustments, which consist of normal recurring accruals and non-recurring adjustments, considered necessary for a fair presentation have been included.

These condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and footnotes thereto included in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2023.

Operating results for the three months ended March 31, 2024 are not necessarily indicative of the results that may be expected for the year ending December 31, 2024.

The Company’s business and working capital needs are seasonal, with a majority of sales occurring in the third and fourth quarters. In 2023 and 2022, net sales for the third and fourth quarters accounted for 57% and 54% of total annual net sales, respectively. In anticipation of the pre-holiday shipping season, inventory levels increase primarily in the June through October time period.

The Company’s current estimates contemplate current and expected future conditions, as applicable, however it is reasonably possible that actual conditions could differ from expectations, which could materially affect the Company’s results of operations and financial position.

Revenue recognition

The Company sells products wholesale, to retailers and distributors, and retail, directly to the consumer. Wholesale sales and retail sales are primarily recognized at the point in time the customer obtains control of the products, in an amount that reflects the consideration the Company expects to be entitled to in exchange for those products.

The Company offers various sales incentives and promotional programs to its customers in the normal course of business. These incentives and promotions typically include arrangements such as cooperative advertising, buydowns, volume rebates and discounts. These arrangements and an estimate for products expected to be returned are reflected as reductions of revenue at the time of sale. See NOTE 2 —REVENUE to the unaudited condensed consolidated financial statements included in this Quarterly Report on Form 10-Q for additional information.

Cost of sales

Cost of sales consist primarily of costs associated with the production and procurement of product, inbound freight costs, purchasing costs, royalties, and other product procurement related charges.

- 7 -

Table of Contents

LIFETIME BRANDS, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

March 31, 2024

(unaudited)

Distribution expenses

Distribution expenses consist primarily of warehousing expenses and freight-out expenses. Handling costs of products sold are included in cost of sales.

Accounts receivable

The Company periodically reviews the collectability of its accounts receivable and establishes allowances for estimated credit losses that could result from the inability of its customers to make required payments, taking into consideration customer credit history and financial condition, industry and market segment information, credit reports, and expectations of current and future economic conditions. A considerable amount of judgment is required to assess the ultimate realization of these receivables, including assessing the initial and on-going creditworthiness of the Company’s customers.

The Company also maintains an allowance for anticipated customer deductions. The allowances for deductions are primarily based on contracts with customers. However, in certain cases, the Company does not have a formal contract and, therefore, customer deductions are non-contractual. To evaluate the reasonableness of non-contractual customer deductions, the Company analyzes currently available information and historical trends of deductions.

Receivable purchase agreement

The Company has an uncommitted Receivables Purchase Agreement with HSBC Bank USA, National Association (“HSBC”) as Purchaser (the “Receivables Purchase Agreement”). The sale of accounts receivable, under the Receivables Purchase Agreement with HSBC, is excluded from the Company’s unaudited condensed consolidated balance sheets at the time of sale and the related sale expense is included in selling, general and administrative expenses in the Company’s unaudited condensed consolidated statements of operations. The Company did not sell receivables to HSBC during the three months ended March 31, 2024 and March 31, 2023.

At March 31, 2024, $23.8 million of accounts receivables were available for sale to HSBC, net of applicable charges.

Inventory

Inventory consists principally of finished goods sourced from third-party suppliers. Inventory also includes finished goods, work in process and raw materials related to the Company’s manufacture of sterling silver products. Inventory is priced using the lower of cost (first-in, first-out basis) or net realizable value. The Company estimates the selling price of its inventory on a product-by-product basis based on the current selling environment. If the estimated selling price is lower than the inventory’s cost, the Company reduces the value of the inventory to its net realizable value. Net realizable value is the estimated selling price in the ordinary course of business, less reasonably predictable cost of completion, disposal and transportation.

The components of inventory were as follows (in thousands):


	March 31, 2024		December 31, 2023
Finished goods	$	181,627	$	180,860
Work in process	164		106
Raw materials	8,029		7,681
Total	$	189,820	$	188,647

- 8 -

Table of Contents

LIFETIME BRANDS, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

March 31, 2024

(unaudited)

Fair value of financial instruments

The Company determined that the carrying amounts of cash and cash equivalents, accounts receivable and accounts payable are reasonable estimates of their fair values because of their short-term nature. The Company determined that the carrying amounts of borrowings outstanding under its ABL Agreement and Term Loan (each as defined in NOTE 6 — DEBT to the unaudited condensed consolidated financial statements included in this Quarterly Report on Form 10-Q) approximate fair value since such borrowings bear interest at variable market rates.

Derivatives

The Company accounts for derivative instruments in accordance with Accounting Standard Codification (“ASC”) Topic 815, Derivatives and Hedging (“ASC 815”). ASC 815 requires that all derivative instruments be recognized on the balance sheet at fair value as either an asset or liability. Changes in the fair value of derivatives that qualify as hedges and have been designated as part of a hedging relationship for accounting purposes have no net impact on earnings until the hedged item is recognized in earnings. The changes in the fair value of hedges are included in accumulated other comprehensive loss and are subsequently recognized in the Company’s unaudited condensed consolidated statements of operations to mirror the location of the hedged items impacting earnings. Changes in fair value of derivatives that do not qualify as hedging instruments for accounting purposes are recorded in the Company’s unaudited condensed consolidated statements of operations.

Goodwill, intangible assets and long-lived assets

Goodwill and intangible assets deemed to have indefinite lives are not amortized but, instead, are subject to an annual impairment assessment. Additionally, if events or conditions were to indicate the carrying value of a reporting unit may not be recoverable, the Company would evaluate goodwill and other intangible assets for impairment at that time.

As it relates to the goodwill assessment, the Company first assesses qualitative factors to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying amount as a basis for determining whether it is necessary to perform the quantitative goodwill impairment testing described in the Financial Accounting Standards Board's (“FASB”) Accounting Standards Update No. (“ASU”) Topic 350, Intangibles – Goodwill and Other. If, after assessing qualitative factors, the Company determines that it is not more likely than not that the fair value of a reporting unit is less than its carrying amount, then performing the quantitative test is unnecessary and the Company’s goodwill is considered to be unimpaired. However, if based on the Company’s qualitative assessment it concludes that it is more likely than not that the fair value of the reporting unit is less than its carrying amount, or if the Company elects to bypass the qualitative assessment, the Company will proceed with performing the quantitative impairment test.

The Company reviews goodwill and other intangibles that have indefinite lives for impairment annually as of October 1 or when events or changes in circumstances indicate the carrying value of these assets might exceed their current fair values. Impairment testing is based upon the best information available, including estimates of fair value which incorporate assumptions marketplace participants would use in making their estimates of fair value. The Company performed its annual impairment assessment of its U.S. reporting unit as of October 1, 2023 by comparing the fair value of the reporting unit with its carrying value. The Company performed the analysis using a discounted cash flow and market multiple method. As of October 1, 2023, the fair value of the U.S. reporting unit exceeded the carrying value of goodwill by 4%.

The significant assumptions used under the income approach, or discounted cash flow method, are projected net sales, projected earnings before interest, tax, depreciation and amortization (“EBITDA”) and the cost of capital. Projected net sales and projected EBITDA were determined to be significant assumptions because they are the primary drivers of the projected cash flows in the discounted cash flow fair value model. Cost of capital was also determined to be a significant assumption as it is the discount rate used to calculate the current fair value of those projected cash flows.

Although the Company believes the assumptions and estimates made are reasonable and appropriate, different assumptions and estimates could materially impact its reported financial results. In addition, sustained declines in the Company’s stock price and related market capitalization could impact key assumptions in the overall estimated fair values of its reporting units and could result in non-cash impairment charges that could be material to the Company’s consolidated balance sheet or results of operations. Should the carrying value of a reporting unit be in excess of the estimated fair value of that reporting unit, an impairment charge will be recorded to reduce the reporting unit to fair value.

- 9 -

Table of Contents

LIFETIME BRANDS, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

March 31, 2024

(unaudited)

The Company also evaluates qualitative factors to determine whether impairment indicators exist for its indefinite-lived intangibles and performs quantitative tests if required. These tests can include the relief from royalty model or other valuation models. The significant assumptions used in the relief from royalty model are future net sales for the related brands, royalty rates and the cost of capital to determine the fair value of the indefinite-lived intangibles. The Company completed the quantitative impairment analysis for its indefinite-lived assets as of October 1, 2023, by comparing the fair value of the indefinite-lived trade names to their respective carrying value using a relief from royalty method. As of October 1, 2023, the fair value of the Company’s indefinite-lived trade names exceeded their respective carrying values by 7%. While the indefinite-lived trade name was not determined to be impaired, if the indefinite-lived trade name does not perform as projected or if market factors utilized in the impairment analysis deteriorate, including an unfavorable change in the weighted average cost of capital, could materially affect the expected cash flows, and such impacts could potentially result in a material non-cash impairment charge.

Long-lived assets, including intangible assets deemed to have finite lives, are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Impairment indicators include, among other conditions, cash flow deficits, historic or anticipated declines in revenue or operating profit or material adverse changes in the business climate that indicate that the carrying amount of an asset may be impaired. When impairment indicators are present, the recoverability of the asset is measured by comparing the carrying value of the asset to the estimated undiscounted future cash flows expected to be generated by the asset. If the carrying amount of the asset is not recoverable, the impairment to be recognized is measured by the amount by which the carrying amount of each long-lived asset exceeds the fair value of the asset.

See NOTE 5 — INTANGIBLE ASSETS to the unaudited condensed consolidated financial statements included in this Quarterly Report on Form 10-Q for additional information.

Leases

The Company determines if an arrangement is a lease at the inception of a contract. Operating lease right-of-use (“ROU”) assets are included in operating lease right-of-use assets on the condensed consolidated balance sheets. The current and long-term components of operating lease liabilities are included in the current portion of operating lease liability and operating lease liabilities, respectively, on the condensed consolidated balance sheets. Finance leases are included in property and equipment, net, accrued expenses and other long-term liabilities. The Company’s finance leases are not material to the Company’s condensed consolidated balance sheets.

Operating lease ROU assets and operating lease liabilities are recognized based on the present value of the future minimum lease payments over the lease term. As most of the Company’s leases do not provide an implicit rate, the Company uses an incremental borrowing rate based on the information available at the commencement date in determining the present value of future payments. The operating lease ROU asset may also include any lease payments made, adjusted for any prepaid or accrued rent payments, lease incentives, and initial direct costs incurred. Certain leases may include options to extend or terminate the lease. Lease expense for minimum lease payments is recognized on a straight-line basis over the lease term.

For certain equipment leases, the Company applies a portfolio approach to effectively account for any ROU assets and lease liabilities. Leases with an initial term of twelve months or less are not recorded on the balance sheet.

The Company has elected the practical expedient to account for each separate lease component of a contract and its associated non-lease components as a single lease component, thus causing all fixed payments to be capitalized.

Employee healthcare

The Company self-insures certain portions of its health insurance plan. The Company maintains an accrual for estimated unpaid claims and claims incurred but not yet reported (“IBNR”). Although management believes that it uses the best information available to estimate IBNR claims, actual claims may vary significantly from estimated claims.

- 10 -

Table of Contents

LIFETIME BRANDS, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

March 31, 2024

(unaudited)

Restructuring expenses

Costs associated with restructuring activities are recorded at fair value when a liability has been incurred. Generally, a liability has been incurred at the communication date for severance. Charges associated with lease terminations, related to restructuring activities, are recognized at the effective date of the lease modification.

During the three months ended March 31, 2023, the Company incurred $0.8 million of unallocated corporate expense related to the termination payment with its former Executive Chairman, Jeffrey Siegel (the “Executive Chairman”). On November 1, 2022, the Company entered into a transition agreement with its Executive Chairman which terminated his employment with the Company, effective March 31, 2023. The employment agreement provided for a one-time payment, which was paid on April 7, 2023.

New accounting pronouncements

Updates not listed below were assessed and either determined to not be applicable or are expected to have a minimal effect on the Company’s financial position, results of operations, and disclosures.

In November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures: which enhances the disclosures required for operating segments in the Company’s annual and interim consolidated financial statements. The new guidance is effective for public business entities for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024 on a retrospective basis. Early adoption is permitted. Management is currently evaluating the impact of this standard on its consolidated financial statements and related disclosures.

In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures: This guidance is intended to enhance the transparency and decision usefulness of income tax disclosures. The amendments in ASU 2023-09 address investor requests for enhanced income tax information primarily through changes to the rate reconciliation and income taxes paid information. Early adoption is permitted. The new guidance is effective for public business entities for annual periods beginning after December 15, 2024 on a prospective basis. Retrospective application is permitted. Management is currently evaluating the impact of this standard on its consolidated financial statements and related disclosures.

NOTE 2 —REVENUE

The Company sells products wholesale, to retailers and distributors, and sells products retail, directly to consumers. Wholesale sales and retail sales are recognized at the point in time the customer obtains control of the products in an amount that reflects the consideration the Company expects to be entitled to in exchange for those products. To indicate the transfer of control, the Company must have a present right to payment, legal title must have passed to the customer, the customer must have the significant risks and rewards of ownership, and where acceptance is not a formality, the customer must have accepted the product or service. The Company’s principal terms of sale are Free On Board (“FOB”) Shipping Point, or equivalent, and, as such, the Company primarily transfers control and records revenue for product sales upon shipment. Sales arrangements with delivery terms that are not FOB Shipping Point are not recognized upon shipment and the transfer of control for revenue recognition is evaluated based on the associated shipping terms and customer obligations. Shipping and handling fees that are billed to customers in sales transactions are included in net sales and amounted to $0.6 million and $0.5 million for the three months ended March 31, 2024 and 2023, respectively. Net sales exclude taxes that are collected from customers and remitted to the taxing authorities.

The Company offers various sales incentives and promotional programs to its wholesale customers from time to time in the normal course of business. These incentives and promotions typically include arrangements such as cooperative advertising, buydowns, volume rebates and discounts. These sales incentives and promotions represent variable consideration and are reflected as reductions in net sales in the Company’s unaudited condensed consolidated statements of operations. While many of the sales incentives and promotions are contractually agreed upon with the Company’s customers, certain of the sales incentives and promotions are non-contractual and require the Company to estimate the amount of variable consideration based on historical experience and other known factors or as the most likely amount in a range of possible outcomes. On a quarterly basis, variable consideration is assessed on a portfolio approach in estimating the extent to which the components of variable

- 11 -

Table of Contents

LIFETIME BRANDS, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

March 31, 2024

(unaudited)

consideration are constrained. Payment terms vary by customer, but generally range from 30 to 90 days or at the point of sale for the Company’s retail direct sales.

The Company incurs certain direct incremental costs to obtain contracts with customers, such as sales-related commissions, where the recognition period for the related revenue is less than one year. These costs are expensed as incurred and recorded within selling, general and administrative expenses in the unaudited condensed consolidated statements of operations. Incidental items that are immaterial in the context of the contract are expensed as incurred.

The following tables present the Company’s net sales disaggregated by segment, product category and geographic region for the three months ended March 31, 2024 and 2023 (in thousands):


	Three Months Ended
	March 31,
	2024		2023
U.S. segment
Kitchenware	$	83,530	$	85,732
Tableware	25,759		23,999
Home Solutions	21,191		23,754
Total U.S. segment	130,480		133,485



International segment	11,762		11,950
Total net sales	$	142,242	$	145,435

United States	$	120,503	$	127,246
United Kingdom	7,466		8,612
Rest of World	14,273		9,577
Total net sales	$	142,242	$	145,435

NOTE 3 — LEASES

The Company has operating leases for corporate offices, distribution facilities, a manufacturing plant, and certain vehicles.

The components of lease expense for the three months ended March 31, 2024 and 2023 were as follows (in thousands):


	Three Months Ended March 31,
	2024		2023
Operating lease expenses(1):
Fixed lease expense	$	4,263	$	4,174
Variable lease expense	1,368		1,426
Total	$	5,631	$	5,600

(1) Expenses are recorded within distribution expenses and selling, general and administrative expenses on the unaudited condensed consolidated statement of operations.

- 12 -

Table of Contents

LIFETIME BRANDS, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

March 31, 2024

(unaudited)

Supplemental cash flow information for lease related liabilities and assets for the three months ended March 31, 2024 and 2023 were as follows (in thousands):


	Three Months Ended March 31,
	2024		2023
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows for operating leases	$	4,718	$	4,887


	Three Months Ended March 31,
	2024		2023
Right-of-use assets obtained in exchange for lease obligations:
Operating leases	$	—	$	1,184

The aggregate future lease payments for operating leases as of March 31, 2024 were as follows (in thousands):


	Operating
2024 (excluding the three months ended March 31, 2024)	$	14,231
2025	18,721
2026	18,348
2027	14,219
2028	12,824
2029	6,678
Thereafter	11,749
Total lease payments	96,770
Less: Interest	(16,241)
Present value of lease payments	$	80,529

Average lease terms and discount rates were as follows:


	March 31, 2024
Operating leases:
Weighted-average remaining lease term (years)	5.7
Weighted-average discount rate	6.4	%

NOTE 4 —INVESTMENTS

As of March 31, 2024, the Company owned 24.7% of the outstanding capital stock of Grupo Vasconia S.A.B. (“Vasconia”), an integrated manufacturer of aluminum products and a housewares company in Mexico. Shares of Vasconia’s capital stock are traded on the Bolsa Mexicana de Valores, the Mexican Stock Exchange. The Quotation Key is VASCONI. The Company accounts for its investment in Vasconia using the equity method of accounting and records its proportionate share of Vasconia’s net loss in the Company’s condensed consolidated statements of operations. Accordingly, the Company has recorded its proportionate share of Vasconia’s net loss for the three months ended March 31, 2024 and 2023 in the accompanying unaudited condensed consolidated statements of operations.

The Company’s equity in losses, net of taxes, for the three months ended March 31, 2024 and 2023 included the following:

- 13 -

Table of Contents

LIFETIME BRANDS, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

March 31, 2024

(unaudited)


	Three Months Ended March 31,
	2024		2023
Vasconia equity in losses, net of taxes	$	(2,092)	$	(724)
Impairment on investment in Vasconia	—		(2,053)
Equity in losses, net of taxes	$	(2,092)	$	(2,777)

The effect of the translation of the Company’s investment, as well as the translation of Vasconia’s balance sheet, resulted in an increase to the investment of $0.3 million and an increase of $0.7 million during the three months ended March 31, 2024 and 2023, respectively. These translation effects are recorded in accumulated other comprehensive loss. The carrying value of the Company’s investment in Vasconia, was zero and $1.8 million as of March 31, 2024 and December 31, 2023, respectively.

Amounts due to and from Vasconia are recorded in the Company’s unaudited condensed consolidated balance sheet within prepaid expenses, other current assets, accrued expenses and accounts payable. As of March 31, 2024 and December 31, 2023, these amounts were not material individually or in the aggregate.

On April 29, 2024, Vasconia’s shareholders’ approved a resolution to a reorganization process in terms of the Law of Commercial Bankruptcy in Mexico. In the second quarter of fiscal 2024, the Company will assess the impact of the approved reorganization process on its ability to exercise significant influence to determine if equity method accounting for its investment remains appropriate. In the event that the Company no longer exercises significant influence, the investment would not be accounted for using the equity method of accounting which may result in the recognition of a non-cash loss for amounts previously recognized in accumulated other comprehensive loss. At March 31, 2024, the accumulated other comprehensive loss related to the investment was $14.2 million.

NOTE 5 — INTANGIBLE ASSETS

Intangible assets consisted of the following as of March 31, 2024 and December 31, 2023 (in thousands):


	March 31, 2024				December 31, 2023
	Gross		Accumulated Amortization		Net		Gross		Accumulated Amortization		Net
Goodwill(1)	$	33,237	$	—	$	33,237	$	33,237	$	—	$	33,237
Indefinite-lived intangible assets:
Trade names(1)	42,000		—		42,000		42,000		—		42,000
Finite-lived intangible assets:
Licenses	15,847		(12,224)		3,623		15,847		(12,110)		3,737
Trade names(2)	62,475		(24,896)		37,579		62,493		(23,862)		38,631
Customer relationships(2)	143,157		(66,124)		77,033		143,158		(63,630)		79,528
Other (2)	5,870		(3,999)		1,871		5,872		(3,872)		2,000
Total	$	302,586	$	(107,243)	$	195,343	$	302,607	$	(103,474)	$	199,133

(1) The gross and net value at March 31, 2024 and December 31, 2023 reflect a reduction of $91.7 million in impairment charges on goodwill and $1.0 million in impairment charges on indefinite-lived intangible assets.

(2) The gross value and accumulated amortization at March 31, 2024 and December 31, 2023 reflect a reduction of $44.1 million and $(29.3) million, respectively, for the net $14.8 million previous impairment charge on finite-lived intangible assets within the international segment and a $6.5 million reduction in gross value for previous impairment charges on finite-lived intangible assets within the U.S. segment.

NOTE 6 — DEBT

- 14 -

Table of Contents

LIFETIME BRANDS, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

March 31, 2024

(unaudited)

Agreement provides for a senior secured asset-based revolving credit facility in the maximum aggregate principal amount of $200.0 million, which facility will mature on August 26, 2027.

On November 14, 2023, the Company entered into Amendment No. 2 to amend the Loan Agreement, dated as of March 2, 2018, among the Company, as borrower, the other loan parties from time to time party thereto, the lenders from time to time party thereto, and JPMorgan Chase Bank, N.A., as Administrative Agent (as amended, the “Term Loan” and together with the ABL Agreement, the “Debt Agreements”). The Term Loan has a principal amount of $150.0 million, and matures on August 26, 2027.

The Term Loan requires the Company to make quarterly payments of principal each equal to 1.25% of the aggregate principal amount of the Term Loan, commencing on March 31, 2024, with the remaining balance payable on the maturity date. The Term Loan requires the Company to make an annual prepayment of principal, beginning with those for the fiscal year ending December 31, 2024, based upon a percentage of the Company’s excess cash flow, (“Excess Cash Flow”), if any. The percentage applied to the Company’s excess cash flow is based on the Company’s Total Net Leverage Ratio (as defined in the Debt Agreements). When an Excess Cash Flow payment is required, each lender has the option to decline a portion or all of the prepayment amount payable to it. Per the Term Loan, when the Company makes an Excess Cash Flow prepayment, the payment is first applied to satisfy the next eight (8) scheduled future quarterly required payments of the Term Loan in order of maturity and then to the remaining scheduled installments on a pro rata basis.

The maximum borrowing amount under the ABL Agreement may be increased to up to $250.0 million if certain conditions are met. One or more tranches of additional term loans (the “Incremental Term Facilities”) may be added under the Term Loan if certain conditions are met. The Incremental Facilities may not exceed the sum of (i) $50.0 million plus (ii) an unlimited amount so long as, in the case of (ii) only, the Company’s secured net leverage ratio, as defined in and computed on a pro forma basis pursuant to the Term Loan, after giving effect to such increase, is no greater than 3.25 to 1.00, subject to certain limitations and for the period defined pursuant to the Term Loan but not to mature earlier than the maturity date of the then existing term loans.

As of March 31, 2024 and December 31, 2023, the total availability under the ABL Agreement were as follows (in thousands):


	March 31, 2024		December 31, 2023
Maximum aggregate principal allowed	$	146,084	$	181,919
Outstanding borrowings under the ABL Agreement	(40,860)		(60,395)
Standby letters of credit	(8,522)		(2,894)
Total availability under the ABL Agreement	$	96,702	$	118,630

Availability under the ABL Agreement is limited to the lesser of the $200.0 million commitment thereunder and the borrowing base and therefore depends on the valuation of certain current assets comprising the borrowing base. The borrowing capacity under the ABL Agreement will depend, in part, on eligible levels of accounts receivable and inventory that fluctuate regularly. Due to the seasonality of the Company’s business, the Company may have greater borrowing availability during the third and fourth quarters of each year. Consequently, the $200.0 million commitment thereunder may not represent actual borrowing capacity. The Company’s borrowing capacity may be further limited by the Term Loan financial covenant of 5.00 to 1.00 maximum Total Net Leverage Ratio.

- 15 -

Table of Contents

LIFETIME BRANDS, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

March 31, 2024

(unaudited)

The current and non-current portions of the Company’s Term Loan included in the condensed consolidated balance sheets were as follows (in thousands):


	March 31, 2024		December 31, 2023
Current portion of Term Loan:
Term Loan payment	$	9,375	$	7,500
Estimated Excess Cash Flow principal payment	4,000		—
Estimated unamortized debt issuance costs	(2,723)		(2,758)
Total Current portion of Term Loan	$	10,652	$	4,742

Non-current portion of Term Loan:
Term Loan, net of current portion	$	136,625	$	142,500
Estimated unamortized debt issuance costs	(5,999)		(6,666)
Total Non-current portion of Term Loan	$	130,626	$	135,834

The estimated Excess Cash Flow principal payment recorded at March 31, 2024 represents the Company’s estimate for the Excess Cash Flow Payment due in 2025. There was no Excess Cash Flow payment due in 2024.

The Company’s payment obligations under its Debt Agreements are unconditionally guaranteed by its existing and future U.S. subsidiaries with certain minor exceptions. Certain payment obligations under the ABL Agreement are also direct obligations of its foreign subsidiary borrowers designated as such under the ABL Agreement and, subject to limitations on such guaranty, are guaranteed by the foreign subsidiary borrowers, as well as by the Company. The obligations of the foreign subsidiary borrowers under the ABL Agreement are secured by security interests in substantially all of the assets of, and stock in, such foreign subsidiary borrowers, subject to certain limitations. The obligations of the Company under the Debt Agreements and any hedging arrangements and cash management services and the guarantees by its domestic subsidiaries in respect of those obligations are secured by security interests in substantially all of the assets and stock (but in the case of foreign subsidiaries, limited to 65% of the capital stock in first-tier foreign subsidiaries and not including the stock of subsidiaries of such first-tier foreign subsidiaries) owned by the Company and the U.S. subsidiary guarantors, subject to certain exceptions. Such security interests consist of (1) a first-priority lien, subject to certain permitted liens, with respect to certain assets of the Company and certain of its subsidiaries (the “ABL Collateral”) pledged as collateral in favor of lenders under the ABL Agreement and a second-priority lien in the ABL Collateral in favor of the lenders under the Term Loan and (2) a first-priority lien, subject to certain permitted liens, with respect to certain assets of the Company and certain of its subsidiaries (the “Term Loan Collateral”) pledged as collateral in favor of lenders under the Term Loan and a second-priority lien in the Term Loan Collateral in favor of the lenders under the ABL Agreement.

Borrowings under the revolving credit facility bear interest, at the Company’s option, at one of the following rates: (i) an alternate base rate, defined, for any day, as the greater of the prime rate, a federal funds and overnight bank funding based rate plus 0.5% or one-month Adjusted Term Secured Overnight Financing Rate (“SOFR”) plus 1.0% as of a specified date in advance of the determination, but in each case not less than 1.0%, plus a margin of 0.25% to 0.50%, or (ii) Adjusted Term SOFR, which is the Term SOFR Rate for the selected 1, 3 or 6 month interest period plus 0.10% (or Euro Interbank Offered Rate “EURIBOR” for borrowings denominated in Euro; or Sterling Overnight Index Average “SONIA” for borrowings denominated in Pounds Sterling), but in each case not less than zero, plus a margin of 1.25% to 1.50%. The respective margins are based upon average quarterly availability, as defined in and computed pursuant to the ABL Agreement. In addition, the Company pays a commitment fee of 0.20% to 0.25% per annum based on the average daily unused portion of the aggregate commitment under the ABL Agreement. The interest rate on outstanding borrowings under the ABL Agreement at March 31, 2024 was between 6.44% and 8.75%. The Company paid a commitment fee of 0.25% on the unused portion of the ABL Agreement during the three months ended March 31, 2024.

- 16 -

Table of Contents

LIFETIME BRANDS, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

March 31, 2024

(unaudited)

the Term SOFR Adjustment) for the applicable interest period, but not less than 1.0%, plus a margin of 5.5%. The interest rate on outstanding borrowings under the Term Loan at March 31, 2024 was 10.94%.

The Debt Agreements provide for customary restrictions and events of default. Restrictions include limitations on additional indebtedness, liens, acquisitions, investments and payment of dividends, among other things. Under the Term Loan, the Total Net Leverage Ratio is not permitted to be greater than 5.00 to 1.00 determined as of the end of each fiscal quarters. Further, the ABL Agreement provides that during any period (a) commencing on the last day of the most recently ended four consecutive fiscal quarters on or prior to the date availability under the ABL Agreement is less than the greater of $20.0 million and 10% of the aggregate commitment under the ABL Agreement at any time and (b) ending on the day after such availability has exceeded the greater of $20.0 million and 10% of the aggregate commitment under the ABL Agreement for 45 consecutive days, the Company is required to maintain a minimum fixed charge coverage ratio of 1.10 to 1.00 as of the last day of any period of four consecutive fiscal quarters.

The Company was in compliance with the covenants of the Debt Agreements at March 31, 2024.

The Company expects that it will continue to borrow, subject to availability, and repay funds under the ABL Agreement based on working capital and other corporate needs.

NOTE 7 — DERIVATIVES

Interest Rate Swap Agreements

In June 2019 the Company entered into interest rate swap agreements, with an aggregate notional value of $25.0 million and expire in February 2025. In March 2024, the Company entered into a new interest rate swap agreement, with an aggregate notional value of $25.0 million and expire in August 2027. These non-designated interest rate swaps serve as cash flow hedges of the Company’s exposure to the variability of the payment of interest on a portion of its Term Loan borrowings. The Company’s total outstanding notional value of interest rate swaps was $50.0 million at March 31, 2024.

The Company’s interest rate swaps that were designated as cash flow hedges of the Company’s exposure to the variability of the payment of interest on a portion of its Term Loan borrowings expired in March 2023. The Company has no designated interest rate swaps at March 31, 2024.

Foreign Exchange Contracts

The Company is party from time to time to certain foreign exchange contracts, primarily to offset the earnings impact related to fluctuations in foreign currency exchange rates associated with inventory purchases denominated in foreign currencies. Fluctuations in the value of certain foreign currencies as compared to the USD may positively or negatively affect the Company’s revenues, gross margins, operating expenses, and retained earnings, all of which are expressed in USD. Where the Company deems it prudent, the Company engages in hedging programs using foreign currency forward contracts aimed at limiting the impact of foreign currency exchange rate fluctuations on earnings. The Company purchases foreign currency forward contracts with terms less than 18 months to protect against currency exchange risks associated with the payment of merchandise purchases to foreign suppliers. The Company does not hedge the translation of foreign currency profits into USD, as the Company regards this as an accounting exposure rather than an economic exposure.

The aggregate gross notional value of foreign exchange contracts at March 31, 2024 was $7.0 million. These foreign exchange contracts have been designated as hedges in order to apply hedge accounting.

The Company is exposed to market risks as well as changes in foreign currency exchange rates as measured against the USD and each other, and to changes to the credit risk of derivative counterparties. The Company attempts to minimize these risks primarily by using foreign currency forward contracts and by maintaining counterparty credit limits. These hedging activities provide only limited protection against currency exchange and credit risk. Factors that could influence the effectiveness of the Company’s hedging programs include those impacting currency markets and the availability of hedging instruments and liquidity of the credit markets. All foreign currency forward contracts that the Company enters into are components of hedging programs and are entered into for the sole purpose of hedging an existing or anticipated currency exposure. The Company does

- 17 -

Table of Contents

LIFETIME BRANDS, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

March 31, 2024

(unaudited)

not enter into such contracts for speculative purposes, and as of March 31, 2024, these foreign exchange contracts have been designated as hedges in to order to apply hedge accounting.

The fair values of the Company’s derivative financial instruments included in the condensed consolidated balance sheets are presented as follows (in thousands):


Derivatives designated as hedging instruments	Balance Sheet Location	March 31, 2024		December 31, 2023




Foreign exchange contracts	Prepaid expenses and other current assets	$	67	$	56

	Accrued expenses	73		144


Derivatives not designated as hedging instruments	Balance Sheet Location	March 31, 2024		December 31, 2023
Interest rate swaps	Prepaid expenses and other current assets	$	722	$	—
	Other assets	—		793
	Other long-term liabilities	104		—

The fair values of the interest rate swaps have been obtained from the counterparties to the agreements and were based on Level 2 observable inputs using proprietary models and estimates about relevant future market conditions. The fair values of the foreign exchange contracts were based on Level 2 observable inputs using quoted market prices for similar assets in an active market. The counterparties to the derivative financial instruments are major international financial institutions. The Company is exposed to credit risk for the net exchanges under these agreements, but not for the notional amounts. As of March 31, 2024, the Company did not anticipate non-performance by any of its counterparties.

The amounts of gains and losses, realized and unrealized, related to the Company’s derivative financial instruments designated as hedging instruments are recognized in other comprehensive income, net of taxes, as follows (in thousands):


	Three Months Ended March 31,
Derivatives designated as hedging instruments	2024		2023
Interest rate swaps	$	—	$	(120)
Foreign exchange contracts	201		(1,033)
	$	201	$	(1,153)

Realized gains and losses on the interest rate swaps that are reported in other comprehensive income are reclassified into earnings as the interest expense on the debt is recognized. The Company’s interest rate swaps that were designated as hedging instruments had an aggregate notional value of $25.0 million and matured during the three months ended March 31, 2023.

Realized gains and losses on foreign exchange contracts that are reported in other comprehensive income are reclassified into cost of sales as the underlying inventory purchased is sold.

During the three months ended March 31, 2024, the Company reclassified $0.1 million of cash flow hedges in accumulated other comprehensive losses to earnings. This was related to foreign exchange contracts recognized in cost of sales. At March 31, 2024, the estimated amount of existing net losses expected to be reclassified into earnings within the next 12 months was below $0.1 million.

During the three months ended March 31, 2023, the Company reclassified $0.9 million of cash flow hedges in accumulated other comprehensive losses to earnings. This was comprised of a gain of $0.1 million related to realized interest rate swap and a gain of $0.8 million related to foreign exchange contracts recognized in cost of sales.

- 18 -

Table of Contents

LIFETIME BRANDS, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

March 31, 2024

(unaudited)

Interest and mark to market (losses) related to the Company’s derivative financial instruments not designated as hedging instruments that were recognized in earnings are as follows (in thousands):


		Three Months Ended March 31,
Derivatives not designated as hedging instruments	Location of gain (loss)	2024		2023
Interest rate swaps	Mark to market (loss) on interest rate derivatives	$	(174)	$	(234)
	Interest expense	221		165
		$	47	$	(69)

NOTE 8 — STOCK COMPENSATION

As of March 31, 2024, there were 242,448 shares available for the grant of awards under the Company's Amended and Restated 2000 Long Term Incentive Plan (“Plan”), assuming maximum performance of performance-based awards.

Option Awards

A summary of the Company’s stock option activity and related information for the three months ended March 31, 2024 is as follows:


	Options		Weighted- average exercise price		Weighted- average remaining contractual life (years)	Aggregate intrinsic value (in thousands)
Options outstanding, January 1, 2024	999,500		$	13.31
Grants	50,000		9.76


Expirations	(100,000)		18.04
Options outstanding, March 31, 2024	949,500		12.63		4.6	$	742
Options exercisable, March 31, 2024	806,875		$	13.21	3.8	$	506
Total unrecognized stock option expense remaining (in thousands)	$	556
Weighted-average years expected to be recognized over	1.9

The aggregate intrinsic value in the table above represents the total pre-tax intrinsic value that would have been received by the option holders had all option holders exercised their stock options on March 31, 2024. The intrinsic value is calculated for each in-the-money stock option as the difference between the closing price of the Company’s common stock on March 31, 2024 and the exercise price.

On March 8, 2023, the exercise period for the Executive Chairman’s outstanding vested stock options were extended to remain exercisable until ninety days following termination of his service on the Company's Board of Directors (the “Board”). The outstanding stock options remain subject to original expiration dates of such awards. The Company recorded $0.1 million of stock compensation expense in connection with this extension during the three months ended March 31, 2023.

- 19 -

Table of Contents

LIFETIME BRANDS, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

March 31, 2024

(unaudited)

Restricted Stock

A summary of the Company’s restricted stock activity and related information for the three months ended March 31, 2024 is as follows:


	Restricted Shares		Weighted- average grant date fair value
Non-vested restricted shares, January 1, 2024	597,528		$	8.44
Grants	219,975		9.76
Vested	(140,060)		10.67
Cancellations	(6,814)		10.39
Non-vested restricted shares, March 31, 2024	670,629		$	8.38
Total unrecognized compensation expense remaining (in thousands)	$	4,857
Weighted-average years expected to be recognized over	1.9

The total fair value of restricted stock that vested during the three months ended March 31, 2024 was $1.4 million.

Performance shares

Each performance award represents the right to receive up to 150% of the target number of shares of common stock. The number of shares of common stock earned will be determined based on the attainment of specified performance goals at the end of the performance period, as determined by the Compensation Committee of the Board. The shares are subject to the terms and conditions of the Company’s Plan.

A summary of the Company’s performance-based award activity and related information for the three months ended March 31, 2024 is as follows:


	Performance- based stock awards (1)		Weighted- average grant date fair value
Non-vested performance-based awards, January 1, 2024	486,972		$	10.44
Grants	219,975		9.76

Vested	(152,188)		14.18
Cancellations	(23,047)		13.54
Non-vested performance-based awards, March 31, 2024	531,712		$	8.96
Total unrecognized compensation expense remaining (in thousands)(2)	$	2,720
Weighted-average years expected to be recognized over	2.5

(1)Represents the target number of shares to be issued for each performance-based award.

(2)The performance metric for the performance-based awards granted in 2022 is not probable of achievement. Therefore, no compensation expense has been recorded on these awards.

The total fair value of performance-based awards that vested during the three months ended March 31, 2024 was $1.5 million.

Cash-settled performance-based awards

Each cash-settled performance-based award represents the right to receive up to 150% of the target number of deferred stock units with payment in cash equivalent to the value of one share of the Company's common stock. The number of deferred stock units earned will be determined based on the attainment of specified performance goals at the end of the performance period, as determined by the Compensation Committee of the Board. The cash-settled performance-based awards are subject to the terms and conditions of the Company’s Plan.

- 20 -

Table of Contents

LIFETIME BRANDS, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

March 31, 2024

(unaudited)

A summary of the Company’s cash-settled performance-based awards activity and related information for the three months ended March 31, 2024 is as follows:


	Cash-settled performance-based awards (1)		Weighted- average fair value
Non-vested cash-settled performance-based awards, January 1, 2024	83,611		$	6.71


Cancellations	(1,107)		10.14
Non-vested cash-settled performance-based awards, March 31, 2024	82,504		$	10.48
Total unrecognized compensation expense remaining (in thousands)(2)	$	—
Weighted-average years expected to be recognized over	0.0

(1) Represents the target number of units to be settled in cash.

(2) The performance metric for the cash-settled performance-based awards granted in 2022 is not probable of achievement. Therefore, no compensation expense has been recorded on these awards.

The Company recorded stock compensation expense as follows (in thousands):


	Three Months Ended March 31,
Stock Compensation Expense Components	2024		2023
Equity based stock option expense	$	50	$	129
Restricted and performance-based stock awards expense	749		737
Stock compensation expense for equity based awards	$	799	$	866
Liability based stock option expense	8		(5)

Total Stock Compensation Expense	$	807	$	861

- 21 -

Table of Contents

LIFETIME BRANDS, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

March 31, 2024

(unaudited)

NOTE 9 —LOSS PER COMMON SHARE

Basic loss per common share has been computed by dividing net loss by the weighted-average number of shares of the Company’s common stock outstanding during the relevant period. Diluted loss per common share adjusts net loss and basic loss per common share for the effect of all potentially dilutive shares of the Company’s common stock. Anti-dilutive securities are not included in the computation of diluted earnings per share under the treasury stock method.

The calculations of basic and diluted loss per common share for the three months ended March 31, 2024 and 2023 are as follows:


	Three Months Ended March 31,
	2024		2023
	(in thousands, except per share amounts)
Net loss – Basic and Diluted	$	(6,260)	$	(8,805)
Weighted-average shares outstanding – Basic	21,377		21,225
Effect of dilutive securities:
Stock options and other stock awards	—		—
Weighted-average shares outstanding – Diluted	21,377		21,225
Basic loss per common share	$	(0.29)	$	(0.41)
Diluted loss per common share	$	(0.29)	$	(0.41)
Antidilutive Securities(1)	1,605		1,581

(1) Stock options and other stock awards that have been excluded from the denominator as their inclusion would have been anti-dilutive.

- 22 -

Table of Contents

LIFETIME BRANDS, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

March 31, 2024

(unaudited)

NOTE 10— INCOME TAXES

Income tax provision of $0.2 million and income tax benefit of $1.3 million for the three months ended March 31, 2024 and 2023, respectively, represent taxes on both U.S. and foreign earnings at a combined effective income tax provision rate of (5.3)% and benefit rate of 18.3%, respectively. The negative rate for the three months ended March 31, 2024 reflects tax expense on a pretax financial reporting loss. The effective tax rate for the three months ended March 31, 2024 differs from the federal statutory income tax rate of 21.0% primarily due to the expiration of non-qualified stock options and the vesting of equity-based awards, where the book expense exceeded the tax deduction upon vesting, and foreign losses for which no tax benefit is recognized as such amounts are fully offset with a valuation allowance. The effective tax rate for the three months ended March 31, 2023 differs from the federal statutory income tax rate of 21.0% primarily due to state and local tax expense, the impact of non-deductible expenses, and foreign losses for which no tax benefit is recognized as such amounts are fully offset with a valuation allowance.

The Company has identified the following jurisdictions as “major” tax jurisdictions: U.S. Federal, California, Massachusetts, New Jersey, New York and the United Kingdom.

The Company evaluates its tax positions on a quarterly basis and revises its estimates accordingly. There were no material changes to the Company’s uncertain tax positions, interest, or penalties during the three-month periods ended March 31, 2024 and March 31, 2023.

- 23 -

Table of Contents

LIFETIME BRANDS, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

March 31, 2024

(unaudited)

NOTE 11 – BUSINESS SEGMENTS

The Company has two reportable segments, U.S. and International. The Company has segmented its operations to reflect the manner in which management reviews and evaluates the results of its operations. The U.S. segment includes the Company’s primary domestic business that designs, markets and distributes its products to retailers, distributors and directly to consumers through its own websites. The International segment consists of certain business operations conducted outside the U.S.. Management evaluates the performance of the U.S. and International segments based on net sales and income (loss) from operations. Such measures give recognition to specifically identifiable operating costs such as cost of sales, distribution expenses and selling, general and administrative expenses. Certain general and administrative expenses, such as senior executive salaries and benefits, stock compensation, director fees, and accounting, legal fees and consulting fees, are not allocated to the specific segments and are reflected as unallocated corporate expenses.


	Three Months Ended March 31,
	2024		2023
	(in thousands)
Net sales
U.S.	$	130,480	$	133,485
International	11,762		11,950
Total net sales	$	142,242	$	145,435
Income (loss) from operations
U.S.	$	9,442	$	5,954
International	(3,089)		(1,892)
Unallocated corporate expenses	(4,523)		(5,868)
Income (loss) from operations	$	1,830	$	(1,806)
Depreciation and amortization
U.S.	$	4,656	$	4,618
International	283		252
Total depreciation and amortization	$	4,939	$	4,870


	March 31, 2024		December 31, 2023
	(in thousands)
Assets
U.S.	$	518,377	$	560,716
International	79,650		90,237
Unallocated corporate	4,639		16,189
Total Assets	$	602,666	$	667,142

- 24 -

Table of Contents

LIFETIME BRANDS, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

March 31, 2024

(unaudited)

NOTE 12 — CONTINGENCIES

Wallace EPA Matter

Wallace Silversmiths de Puerto Rico, Ltd. (“WSPR”), a wholly-owned subsidiary of the Company, operates a manufacturing facility in San Germán, Puerto Rico that is leased from the Puerto Rico Industrial Development Company (“PRIDCO”). In March 2008, the U.S. Environmental Protection Agency (the “EPA”) announced that the San Germán Ground Water Contamination site in Puerto Rico (the “Site”) had been added to the Superfund National Priorities List due to contamination present in the local drinking water supply.

In May 2008, WSPR received from the EPA a Notice of Potential Liability and Request for Information pursuant to 42 U.S.C. Sections 9607(a) and 9604(e) of the Comprehensive Environmental Response, Compensation, and Liability Act (“CERCLA”). In July 2011, WSPR received a letter from the EPA requesting access to the property that it leases from PRIDCO to conduct an environmental investigation, and the Company granted such access. In February 2013, the EPA requested access to conduct a further environmental investigation at the property. PRIDCO agreed to such access and the Company consented. The EPA conducted a further investigation during 2013 and, in April 2015, notified the Company and PRIDCO that the results from vapor intrusion sampling may warrant the implementation of measures to mitigate potential exposure to sub-slab soil gas. The Company reviewed the information provided by the EPA and requested that PRIDCO, as the property owner, find and implement a solution acceptable to the EPA. While WSPR did not cause the sub-surface condition that resulted in the potential for vapor intrusion, in order to protect the health of its employees and continue its business operations, it has nevertheless implemented corrective action measures to prevent vapor intrusion, such as sealing the floors of the building and conducting periodic air monitoring to address potential exposure.

On August 13, 2015, the EPA released its remedial investigation and feasibility study (“RI/FS”) for the Site. On December 11, 2015, the EPA issued the Record of Decision (“ROD”) for an initial operable unit (“OU-1”), electing to implement its preferred remedy which consists of soil vapor extraction and dual-phase extraction/in-situ treatment. This selected remedy includes soil vapor extraction (“SVE”) to address soil (vadose zone) source areas at the Site, impermeable cover as necessary for the implementation of SVE, dual phase extraction in the shallow saprolite zone, and in-situ treatment as needed to address residual sources. The EPA’s total net present worth estimated cost for its selected remedy is $7.3 million. In February 2017, the EPA indicated that it planned to expand its field investigation for the RI/FS to a second operable unit (“OU-2”) to determine the nature and extent of the groundwater contamination at and from the Site and to determine the nature of the remedial action needed to address the contamination. The EPA requested access to the property occupied by WSPR to install monitoring wells and to undertake groundwater sampling as part of this expanded investigation. WSPR consented to the EPA’s access request, provided that the EPA received PRIDCO’s consent as the property owner. WSPR never used the primary contaminant of concern and did not take up its tenancy at the Site until after the EPA had discovered the contamination in the local water supply. The EPA has also issued notices of potential liability to a number of other entities affiliated with the Site, which used the contaminants of concern.

In December 2018, the Company, WSPR, and other identified potentially responsible parties affiliated with the Site entered into tolling agreements with the U.S. government to extend the statute of limitations for potential claims for the recovery of response costs for the initial operable unit under Section 107 of CERCLA. The tolling agreements have been extended multiple times and currently expire in November 2025. The tolling agreements do not constitute in any way an admission or acknowledgment of any fact, conclusion of law, or liability by the parties to the agreements.

The EPA released its proposed plan for OU-2 in July 2019, and on September 30, 2019, the EPA issued the ROD for OU-2. The EPA elected to implement its preferred remedy consisting of in-situ treatment of groundwater and a monitored natural attenuation program including monitoring of the plume fringe at the Site. The EPA’s estimated total net present worth cost for its selected remedy for OU-2 is $17.3 million, and the EPA is currently leading remediation of OU-2.

In August 2021, WSPR received a Notice of Liability for the Site from the Department of Justice on behalf of the EPA, and in September 2021, WSPR responded with a good faith offer to conduct additional testing and remedial design work for OU-1. WSPR has actively participated in negotiations among the U.S. Government (the Department of Justice and the EPA) and other potentially responsible parties with respect to the remedial work at OU-1, which negotiations culminated in the finalization of a Consent Decree for Remedial Design and Remedial Action at Operable Unit One of the San German Groundwater Contamination Site (“Consent Decree”). On July 26, 2023, the U.S. Government filed a complaint in United States District

- 25 -

Table of Contents

LIFETIME BRANDS, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

March 31, 2024

(unaudited)

Court for the District of Puerto Rico for the purpose of seeking judicial approval of the Consent Decree. As required by applicable regulations, the U.S. Government simultaneously lodged the Consent Decree for public comment. No comments were received during the public comment period. On September 6, 2023, at the conclusion of the public comment period, the U.S. Government filed a Motion to Enter the Consent Decree, which the court granted on December 1, 2023, thereby effectuating the Consent Decree.

The Company has reserved $5.6 million to cover probable and estimable liabilities with respect to the above remedial design and remedial action for the initial operable unit. However, it is not possible at this time for the Company to estimate its share of its ultimate liability for the Site. In the event of one or more adverse determinations related to this matter, it is possible that the ultimate liability resulting from this matter and the impact on the Company’s results of operations could be material.

U.S. Customs and Border Protection matter

By letter dated August 26, 2019, the Company was advised that U.S. Customs and Border Protection ("CBP") had commenced an investigation, pursuant to 19 U.S.C. §1592, regarding the Company’s tariff classification of certain tableware and kitchenware. The issue centers on whether such merchandise meets the criteria for reduced duty rates as specified sets as those terms are defined in Chapter 69, Note 6(b), Harmonized Tariff System of the United States. The period of investigation is stated to be from August 26, 2014 to the present. Since being notified of the investigation, the Company has obtained a significant amount of evidence that, the Company believes, supports that the imported products were properly classified as specified sets. The Company's counsel filed a Lead Protest and Application for Further Review with CBP on February 5, 2020 (the "Lead Protest") relating to a single shipment made during the investigation period.

CBP approved the Company’s Lead Protest on June 8, 2020 stating that the specified set requirement was fulfilled with respect to the protested shipment based on information provided by the Company. Based on this decision, no additional duties will be owed for the seven tableware collections imported in this shipment.

The Company also compiled and submitted to CBP a complete set of supporting documents for three additional protests (for the remaining 29 tableware collections that were imported by the Company under the protested shipments). One of the additional protests was approved on October 15, 2020; the other two remain pending. If the CBP approves these additional claims and accepts the evidence presented, then no additional duties will be owed for the remaining protested shipments.

Because the period of investigation covers a five-year period, the Company is compiling supporting documentation packages for all tableware collections imported during this period.

In the event CBP accepts the evidence presented, then no additional duties or penalties will be owed. If CBP rejects the Company’s position, then the estimated amount of duties that could be owed is $0.3 million. In such event, it is reasonably possible that additional penalties could be assessed, depending upon the level of culpability found, of up to $0.6 million for negligence and up to $1.2 million for gross negligence. In the event penalties are assessed, the Company will have the opportunity to further contest CBP’s findings and seek cancellation or mitigation of such assessments.

Accordingly, based on the above uncertainties and variables, the Company considers the potential losses related to this matter to be reasonably possible, but not probable. However, in the event of one or more adverse determinations related to this matter, it is possible that the ultimate liability resulting from this matter and the impact on the Company’s results of operations could be material.

Other

The Company is, from time to time, involved in other legal proceedings. The Company believes that other current litigation is routine in nature and incidental to the conduct of the Company’s business and that none of this litigation, individually or collectively, would have a material adverse effect on the Company’s consolidated financial position, results of operations or cash flows.

- 26 -

Table of Contents

LIFETIME BRANDS, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

March 31, 2024

(unaudited)

NOTE 13 — OTHER

Cash dividends

Dividends declared in the three months ended March 31, 2024 were as follows:

Dividend per share

Date declared

Date of record

Payment date

$0.0425

3/8/2024

5/1/2024

5/15/2024

During the three months ended March 31, 2024, the Company paid dividends of $1.0 million. This included payments made on February 15, 2024 of $0.9 million to stockholders of record on February 1, 2024 and payments of $0.1 million for dividends payable upon the vesting of restricted shares and performance shares.

In the three months ended March 31, 2024, the Company reduced retained earnings for the accrual of $0.9 million relating to the dividend payable on May 15, 2024.

Stock repurchase program

On March 14, 2022, the Company announced that its Board authorized the repurchase of up to $20.0 million of the Company’s common stock, replacing the Company’s previously-authorized $10.0 million share repurchase program. The repurchase authorization permits the Company to effect the repurchases from time to time through open market purchases and privately negotiated transactions. No repurchases were effected during the three months ended March 31, 2024. As of March 31, 2024, the remaining dollar amount available for repurchases under the Board authorized plan was $11.1 million.

Supplemental cash flow information


	Three Months Ended March 31,
	2024		2023
	(in thousands)
Supplemental disclosure of cash flow information:
Cash paid for interest	$	5,105	$	5,104
Cash paid for taxes, net of refunds	282		320

- 27 -

Table of Contents

LIFETIME BRANDS, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

March 31, 2024

(unaudited)

Components of accumulated other comprehensive loss, net


	Three Months Ended March 31,
	2024		2023
	(in thousands)
Accumulated translation adjustment:
Balance at beginning of period	$	(32,614)	$	(36,072)
Translation adjustment during period	40		1,561


Balance at end of period	$	(32,574)	$	(34,511)
Accumulated deferred gains (losses) on cash flow hedges:
Balance at beginning of period	$	(134)	$	923
Change in unrealized gains (losses)	70		(250)
Amounts reclassified from accumulated other comprehensive loss:
Settlement of cash flow hedge (1)	131		(903)
Net change in cash flow hedges, net of taxes of $0, $(2)	201		(1,153)
Balance at end of period	$	67	$	(230)
Accumulated effect of retirement benefit obligations:
Balance at beginning of period	$	(751)	$	(705)
Amounts reclassified from accumulated other comprehensive loss: (2)
Amortization of actuarial loss, net of taxes of $(4), $(4)	13		12
Balance at end of period	$	(738)	$	(693)
Total accumulated other comprehensive loss at end of period	$	(33,245)	$	(35,434)

(1)Amounts reclassified are recorded in interest expense and cost of sales on the unaudited condensed consolidated statement of operations.

(2)Amounts are recorded in selling, general and administrative expense on the unaudited condensed consolidated statements of operations.

- 28 -

Table of Contents

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

This Quarterly Report on Form 10-Q of Lifetime Brands, Inc. (the “Company” and, unless the context otherwise requires, references to the “Company” shall include its consolidated subsidiaries), contains “forward-looking statements” as defined by the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical facts contained in this Quarterly Report on Form 10-Q are forward-looking statements. These forward-looking statements include information concerning the Company’s plans, objectives, goals, strategies, future events, future revenues, performance, capital expenditures, financing needs and other information that is not historical information. Many of these statements appear, in particular, in Management’s Discussion and Analysis of Financial Condition and Results of Operations. When used in this Quarterly Report on Form 10-Q, the words “estimates,” “expects,” “intends,” “predicts,” “plans,” “believes,” “may,” “should,” “would,” and variations of such words or similar expressions are intended to identify forward-looking statements. All forward-looking statements, including, without limitation, those based on the Company’s examination of historical operating trends, are based upon the Company’s current expectations and various assumptions. The Company believes there is a reasonable basis for its expectations and assumptions, but there can be no assurance that the Company will realize its expectations or that the Company’s assumptions will prove correct.

There are a number of risks and uncertainties that could cause the Company’s actual results to differ materially from the forward-looking statements contained in this Quarterly Report on Form 10-Q. Important factors that could cause the Company’s actual results to differ materially from those expressed as forward-looking statements include, without limitation, those set forth in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2023 (the “2023 Annual Report on Form 10-K”) in Part I, Item 1A under the heading Risk Factors, and in the Company’s subsequent filings with the U.S. Securities and Exchange Commission (the “SEC”). Such risks, uncertainties and other important factors include, among others, risks related to:

•Macroeconomic conditions, including inflationary impacts and disruptions to the global supply chain;

•Increase in supply chain costs, including raw materials, sourcing, transportation and energy;

•The impact of the United Kingdom's exit from the European Union on the Company's U.K. operations;

•The impact of tariffs and trade policies, particularly with respect to China;

•Legislative or regulatory risks relating to climate change;

•Indebtedness, compliance with credit agreements, and access to credit markets;

•Access to the capital markets and credit markets;

•The seasonality of the Company's cash flows;

•The Company's ability to complete acquisitions or successfully integrate acquisitions;

•Intense market competition, changing customer practices or preferences and inventory rationalization among retailers;

•Dependence on third-party manufacturers;

•Technology, cybersecurity and data privacy risks;

•Geopolitical conditions, including war, conflict, unrest and sanctions, including those related to the conflicts in Ukraine, Israel and surrounding areas;

•Product liability claims; and

•Reputational risks.

There may be other factors that may cause the Company’s actual results to differ materially from the forward-looking statements. Except as may be required by law, the Company undertakes no obligation to publicly update or revise forward-looking statements which may be made to reflect events or circumstances after the date made or to reflect the occurrence of unanticipated events.

The Company is required to file its Annual Reports on Forms 10-K, Quarterly Reports on Forms 10-Q, Current Reports on Form 8-K, and other reports and documents as required from time to time with the SEC. The Company also maintains a website at http://www.lifetimebrands.com. Information contained on this website is not a part of or incorporated by reference into this Quarterly Report on Form 10-Q. The Company makes available on its website the Company’s Annual Report on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K and any amendments to these reports as soon as reasonably practicable after these reports are filed with or furnished to the SEC. Users can access these reports free of charge on the

- 29 -

Table of Contents

Company’s website. The SEC also maintains a website that contains reports, proxy and information statements, and other information regarding the Company’s electronic filings with the SEC at http://www.sec.gov.

The Company intends to use its website as a means of disclosing material non-public information and for complying with its disclosure obligations under Regulation FD. Such disclosures will be included on the Company’s website in the ‘Investor Relations’ section. Accordingly, investors should monitor such portion of the Company’s website, in addition to following the Company's press releases, SEC filings and public conference calls and webcasts.

ABOUT THE COMPANY

The Company designs, sources and sells branded kitchenware, tableware and other products used in the home. The Company’s product categories include two categories of products used to prepare, serve, and consume foods: Kitchenware (kitchen tools and gadgets, cutlery, kitchen scales, thermometers, cutting boards, shears, cookware, pantryware, spice racks, and bakeware) and Tableware (dinnerware, stemware, flatware, and giftware); and one category, Home Solutions, which comprises other products used in the home (thermal beverageware, bath scales, weather and outdoor household products, food storage, neoprene travel products and home décor).

The Company markets several product lines within each of its product categories and under most of the Company’s brands, primarily targeting moderate price points through virtually every major level of trade. The Company believes it possesses certain competitive advantages based on its brands, its emphasis on innovation and new product development, and its sourcing capabilities. The Company owns or licenses a number of leading brands in its industry, including Farberware®, Mikasa®, KitchenAid®, Taylor®, Rabbit®, Pfaltzgraff®, Built NY®, Sabatier®, Fred® & Friends, Kamenstein®, and S'well®. Historically, the Company’s sales growth has come from expanding product offerings within its product categories, developing existing brands, acquiring new brands (including complementary brands in markets outside the United States), and establishing new product categories. Key factors in the Company’s growth strategy have been the selective use and management of the Company’s brands and the Company’s ability to provide a stream of new products and designs. A significant element of this strategy is the Company’s in-house design and development teams that create new products, packaging and merchandising concepts.

RECENT DEVELOPMENTS

The global economy experienced relatively high inflation throughout 2023. As global inflation levels moderate, the impact of elevated inflation and high interest rates may negatively impact consumer spending and buying patterns in 2024. Shifts in consumer spending and buying patterns may directly impact our retailer ordering patterns, which may adversely impact the Company's results. In addition, disruptions in the global supply chain due to attacks on commercial vessels in the Red Sea, may adversely impact the Company’s results due to supply delays and an increase in transportation costs. The Company expects uncertainty as result of these trends in 2024.

BUSINESS SEGMENTS

EQUITY INVESTMENT

- 30 -

Table of Contents

four persons to be nominated as members of Vasconia’s Board of Directors (the "Vasconia Board"). As of March 31, 2024, the Vasconia Board was comprised of eleven members, of whom the Company had zero designated members.

SEASONALITY

Consistent with the seasonality of the Company’s net sales and inventory levels, the Company also experiences seasonality in its inventory turnover and turnover days from one quarter to the next.

CRITICAL ACCOUNTING ESTIMATES

There have been no material changes to the Company’s critical accounting estimates discussed in the 2023 Annual Report on Form 10-K in Item 7 under the heading Management’s Discussion and Analysis of Financial Condition and Results of Operations – Critical Accounting Policies and Estimates.

RESULTS OF OPERATIONS

The following table sets forth statements of operations data of the Company as a percentage of net sales for the periods indicated:


	Three Months Ended March 31,
	2024		2023
Net sales	100.0	%	100.0	%
Cost of sales	59.5		63.0
Gross margin	40.5		37.0
Distribution expenses	11.4		11.6
Selling, general and administrative expenses	27.8		26.1
Restructuring expenses	—		0.5


Income (loss) from operations	1.3		(1.2)
Interest expense	(3.9)		(3.7)
Mark to market loss on interest rate derivatives	(0.2)		(0.2)

Loss before income taxes and equity in losses	(2.8)		(5.1)
Income tax (provision) benefit	(0.1)		0.9
Equity in losses, net of taxes	(1.5)		(1.9)
Net loss	(4.4)	%	(6.1)	%

- 31 -

Table of Contents

MANAGEMENT’S DISCUSSION AND ANALYSIS

THREE MONTHS ENDED MARCH 31, 2024 COMPARED TO THE THREE MONTHS ENDED

MARCH 31, 2023

Net Sales

Consolidated net sales for the three months ended March 31, 2024 were $142.2 million, representing a decrease of $3.2 million, or 2.2%, as compared to net sales of $145.4 million for the corresponding period in 2023. In constant currency, a non-GAAP financial measure, which excludes the impact of foreign exchange fluctuations and was determined by applying 2024 average rates to 2023 local currency amounts, consolidated net sales decreased by $3.7 million, or 2.5%, as compared to consolidated net sales in the corresponding period in 2023.

Net sales for the U.S. segment for the three months ended March 31, 2024 were $130.5 million, a decrease of $3.0 million, or 2.2%, as compared to net sales of $133.5 million for the corresponding period in 2023.

Net sales for the U.S. segment’s Kitchenware product category were $83.5 million for the three months ended March 31, 2024, a decrease of $2.2 million, or 2.6%, as compared to $85.7 million for the corresponding period in 2023. The decrease was driven by sales for kitchen tools and gadgets and barware products, partially offset by higher sales for cutlery and boards.

Net sales for the U.S. segment’s Tableware product category were $25.8 million for the three months ended March 31, 2024, an increase of $1.8 million, or 7.5%, as compared to $24.0 million for the corresponding period in 2023. The increase was attributable to higher dinnerware sales due to a new warehouse club program in 2024.

Net sales for the U.S. segment’s Home Solutions product category were $21.2 million for the three months ended March 31, 2024, a decrease of $2.6 million, or 10.9%, as compared to $23.8 million for the corresponding period in 2023. The decrease was in hydration products and Taylor branded bath measurement products, partially offset by higher sales for Home Décor products.

Net sales for the International segment were $11.7 million for the three months ended March 31, 2024, a decrease of $0.2 million, or 1.7%, as compared to net sales of $11.9 million for the corresponding period in 2023. In constant currency, a non-GAAP financial measure, which excludes the impact of foreign exchange fluctuations, net sales decreased $0.7 million, or 5.3%, as compared to consolidated net sales in the corresponding period in 2023. The decrease was attributable to lower replenishment orders for e-commerce and brick-and-mortar customers, partially offset by higher sales in Australia for the Company's global trading business in Asia.

Gross margin

Gross margin for the three months ended March 31, 2024 was $57.5 million, or 40.5%, as compared to $53.8 million, or 37.0%, for the corresponding period in 2023.

Gross margin for the U.S. segment was $53.3 million, or 40.8%, for the three months ended March 31, 2024, as compared to $48.9 million, or 36.6%, for the corresponding period in 2023. The increase in gross margin percentage was due to lower inbound freight costs and favorable product mix.

Gross margin for the International segment was $4.2 million, or 35.9%, for the three months ended March 31, 2024, as compared to $5.0 million, or 42.0%, for the corresponding period in 2023. The decrease in the gross margin percentage was driven by higher product costs due to unfavorable fluctuations in foreign currency exchange rates.

Distribution expenses

Distribution expenses for the three months ended March 31, 2024 were $16.2 million, as compared to $16.9 million for the corresponding period in 2023. Distribution expenses as a percentage of net sales were 11.4% for the three months ended March 31, 2024, as compared to 11.6% for the three months ended March 31, 2023.

Distribution expenses as a percentage of net sales for the U.S. segment were approximately 10.0% and 10.2% for the three months ended March 31, 2024 and 2023, respectively. As a percentage of sales shipped from the Company’s U.S. warehouses, distribution expenses were 10.5% for the three months ended March 31, 2024 and 2023, respectively. The expenses as a percentage of sales were impacted by improved labor management efficiencies resulting in a decrease of employee expenses and lower storage expenses from lower inventory levels, offset by higher freight out and facility expenses.

- 32 -

Table of Contents

Distribution expenses as a percentage of net sales for the International segment were 27.2% for the three months ended March 31, 2024, compared to 28.0% for the corresponding period in 2023. As a percentage of sales shipped from the Company’s international warehouses distribution expenses were 23.6% and 24.0% for the three months ended March 31, 2024 and 2023, respectively. The decrease in expenses as a percentage of sales was attributable to lower freight costs.

Selling, general and administrative expenses

Selling, general and administrative expenses for the three months ended March 31, 2024 were $39.5 million, an increase of $1.6 million, or 4.2%, as compared to $37.9 million for the corresponding period in 2023.

Selling, general and administrative expenses for the U.S. segment were $30.8 million for the three months ended March 31, 2024, as compared to $29.3 million for the corresponding period in 2023. As a percentage of net sales, selling, general and administrative expenses were 23.6% and 21.9% for the three months ended March 31, 2024 and 2023, respectively. The increase in expenses was attributable to higher employee expenses, including incentive compensation, legal expenses, expenses related to the start-up of the Company's manufacturing operations in Mexico, and inflationary increases across several expense categories. This was partially offset by a decrease in the provision for doubtful accounts in the current period.

Selling, general and administrative expenses for the International segment were $4.2 million for the three months ended March 31, 2024, as compared to $3.6 million for the corresponding period in 2023. As a percentage of net sales, selling, general and administrative expenses were 35.9% and 30.0% for the three months ended March 31, 2024 and 2023, respectively. The increase in expenses was attributable to increased employee expenses and commission expense.

Unallocated corporate expenses for the three months ended March 31, 2024 were $4.5 million, as compared to $5.0 million for the corresponding period in 2023. The current period decrease was driven by lower professional services and legal expenses.

Restructuring expense

For the three months ended March 31, 2023, the Company incurred $0.8 million of unallocated corporate expense related to the termination payment with its former Executive Chairman.

Interest expense

Interest expense was $5.6 million and $5.3 million for the three months ended March 31, 2024 and 2023, respectively. The increase in expense was a result of higher interest rates on outstanding borrowings, partially offset by lower average outstanding borrowings.

Mark to market loss on interest rate derivatives

Mark to market loss on interest rate derivatives was $0.2 million for the three months ended March 31, 2024 and 2023. The loss recognized for the three months ended March 31, 2024 and 2023 was attributable to the change in the fair value due to the change in the projected interest rate environment. The mark to market amount represents the change in fair value on the Company’s interest rate derivatives that have not been designated as hedging instruments. These derivatives were entered into for purposes of locking-in a fixed interest rate on a portion of the Company’s variable interest rate debt. As of March 31, 2024, the intent of the Company is to hold these derivative contracts until their maturity.

Income taxes

Equity in losses

Equity in losses of Vasconia, net of taxes, was $2.1 million for the three months ended March 31, 2024, as compared to equity in losses of Vasconia, net of taxes, of $0.7 million for the three months ended March 31, 2023. For the three months ended

- 33 -

Table of Contents

March 31, 2023, equity in losses included a non-cash impairment charge of $2.1 million, to reduce the carrying value of the Company’s investment in Vasconia to its fair value.

Vasconia reported loss from operations of $6.9 million for the three months ended March 31, 2024, as compared to loss from operations of $1.0 million for the three months ended March 31, 2023. The increase in loss from operations was primarily attributable to decreased operating results in the current period.

LIQUIDITY AND CAPITAL RESOURCES

The Company’s principal sources of cash to fund liquidity needs are: (i) cash provided by operating activities and (ii) borrowings available under its revolving credit facility under the ABL Agreement, as defined below. The Company’s primary uses of funds consist of working capital requirements, capital expenditures, acquisitions and investments, payments of dividends, and payments of principal and interest on its debt.

At March 31, 2024, the Company had cash and cash equivalents of $4.6 million, compared to $16.2 million at December 31, 2023. Working capital was $199.0 million at March 31, 2024, compared to $224.4 million at December 31, 2023. Liquidity as of March 31, 2024 was $125.1 million, consisting of $4.6 million of cash and cash equivalents, $96.7 million of availability under the ABL Agreement, and $23.8 million of available funding under the Receivables Purchase Agreement.

Inventory, a large component of the Company’s working capital, is expected to fluctuate from period to period, with inventory levels higher primarily in the June through October time period. The Company also expects inventory turnover to fluctuate from period to period based on product and customer mix. Certain product categories have lower inventory turnover rates as a result of minimum order quantities from the Company’s vendors or customer replenishment needs. Certain other product categories experience higher inventory turns due to lower minimum order quantities or trending sale demands. For the three months ended March 31, 2024, inventory turnover was 1.8 times, or 203 days, as compared to 1.7 times, or 212 days, for the three months ended March 31, 2023. Inventory turns have remained relatively consistent.

On February 7, 2024, in connection with the Wallace EPA Matter, the Company provided financial assurance of $5.6 million in the form of a letter of credit. This reduced the availability under the revolving credit facility in the period.

The Company believes that availability under the revolving credit facility under its ABL Agreement, cash on hand and cash flows from operations are sufficient to fund the Company’s operations for the next twelve months. However, if circumstances were to adversely change, the Company may seek alternative sources of liquidity including debt and/or equity financing. However, there can be no assurance that any such alternative sources would be available or sufficient.

The Company closely monitors the creditworthiness of its customers. Based upon its evaluation of changes in customers’ creditworthiness, the Company may modify credit limits and/or terms of sale. However, notwithstanding the Company’s efforts to monitor its customers’ financial condition, the Company could be materially adversely affected by future changes in these conditions.

Indebtedness

On August 26, 2022, the Company entered into Amendment No. 2 (the “Amendment”) to the Company’s credit agreement, dated as of March 2, 2018 (as amended, the “ABL Agreement”) among the Company, as a Borrower, certain subsidiaries of the Company, as Borrowers and/or Loan Parties, JPMorgan Chase Bank, N.A., as Administrative Agent and a Lender. The ABL Agreement provides for a senior secured asset-based revolving credit facility in the maximum aggregate principal amount of $200.0 million, which facility will mature on August 26, 2027.

- 34 -

Table of Contents

Debt Agreements). When an Excess Cash Flow payment is required, each lender has the option to decline a portion or all of the prepayment amount payable to it. Per the Term Loan, when the Company makes an Excess Cash Flow prepayment, the payment is first applied to satisfy the next eight (8) scheduled future quarterly required payments of the Term Loan in order of maturity and then to the remaining scheduled installments on a pro rata basis.

As of March 31, 2024 and December 31, 2023, the total availability under the ABL Agreement were as follows (in thousands):


	March 31, 2024		December 31, 2023
Maximum aggregate principal allowed	$	146,084	$	181,919
Outstanding borrowings under the ABL Agreement	(40,860)		(60,395)
Standby letters of credit	(8,522)		(2,894)
Total availability under the ABL Agreement	$	96,702	$	118,630

The current and non-current portions of the Company’s Term Loan included in the condensed consolidated balance sheets were as follows (in thousands):


	March 31, 2024		December 31, 2023
Current portion of Term Loan:
Term Loan payment	$	9,375	$	7,500
Estimated Excess Cash Flow principal payment	4,000		—
Estimated unamortized debt issuance costs	(2,723)		(2,758)
Total Current portion of Term Loan	$	10,652	$	4,742

Non-current portion of Term Loan:
Term Loan, net of current portion	$	136,625	$	142,500
Estimated unamortized debt issuance costs	(5,999)		(6,666)
Total Non-current portion of Term Loan	$	130,626	$	135,834

- 35 -

Table of Contents

interests consist of (1) a first-priority lien, subject to certain permitted liens, with respect to certain assets of the Company and certain of its subsidiaries (the “ABL Collateral”) pledged as collateral in favor of lenders under the ABL Agreement and a second-priority lien in the ABL Collateral in favor of the lenders under the Term Loan and (2) a first-priority lien, subject to certain permitted liens, with respect to certain assets of the Company and certain of its subsidiaries (the “Term Loan Collateral”) pledged as collateral in favor of lenders under the Term Loan and a second-priority lien in the Term Loan Collateral in favor of the lenders under the ABL Agreement.

The Term Loan bears interest, at the Company’s option, at one of the following rates: (i) alternate base rate, defined, for any day, as the greater of (x) the prime rate, (y) a federal funds and overnight bank funding based rate plus 0.5% or (z) one-month Adjusted Term SOFR, but not less than 1.0%, plus 1.0%, plus a margin of 4.5% or (ii) Adjusted Term SOFR (Term SOFR plus the Term SOFR Adjustment) for the applicable interest period, but not less than 1.0%, plus a margin of 5.5%. The interest rate on outstanding borrowings under the Term Loan at March 31, 2024 was 10.94%.

The Company was in compliance with the covenants of the Debt Agreements at March 31, 2024.

The Company expects that it will continue to borrow, subject to availability, and repay funds under the ABL Agreement based on working capital and other corporate needs.

Covenant Calculations

Adjusted EBITDA (a non-GAAP financial measure), which is defined in the Company’s Debt Agreements, is used in the calculation of the Fixed Charge Coverage Ratio, Secured Net Leverage Ratio, Total Leverage Ratio and Total Net Leverage Ratio, which are required to be provided to the Company’s lenders pursuant to its Debt Agreements.

The Company’s adjusted EBITDA for the trailing twelve months ended March 31, 2024 was $59.5 million.

Capital expenditures for the three months ended March 31, 2024 were $0.6 million.

Non-GAAP financial measure

Adjusted EBITDA is a non-GAAP financial measure within the meaning of Regulation G and Item 10(e) of Regulation S-K, each promulgated by the SEC. This measure is provided because management of the Company uses this financial measure in evaluating the Company’s on-going financial results and trends, and management believes that exclusion of certain items allows for more accurate period-to-period comparison of the Company’s operating performance by investors and analysts. Management also uses this non-GAAP information as an indicator of business performance. Adjusted EBITDA, as discussed above, is also one of the measures used to calculate financial covenants required to be provided to the Company’s lenders pursuant to its Debt Agreements.

- 36 -

Table of Contents

Investors should consider this non-GAAP financial measure in addition to, and not as a substitute for, the Company’s financial performance measures prepared in accordance with U.S. GAAP. Further, the Company’s non-GAAP information may be different from the non-GAAP information provided by other companies including other companies within the home retail industry.

The following is a reconciliation of the net (loss) income, as reported, to adjusted EBITDA, for each of the last four quarters and the 12 months ended March 31, 2024:


	Quarter Ended								Twelve Months Ended March 31, 2024
	June 30, 2023		September 30, 2023		December 31, 2023		March 31, 2024
	(in thousands)
Net (loss) income as reported	$	(6,520)	$	4,206	$	2,707	$	(6,260)	$	(5,867)
Undistributed equity losses, net	5,863		1,047		2,978		2,092		11,980
Income tax provision	1,242		3,015		3,313		210		7,780
Interest expense	5,528		5,246		5,618		5,614		22,006
Depreciation and amortization	4,925		4,821		4,955		4,939		19,640
Mark to market (gain) loss on interest rate derivatives	(197)		98		364		174		439

Stock compensation expense	1,011		898		917		807		3,633



Contingent consideration fair value adjustments	(50)		—		(600)		—		(650)
(Gain) loss on extinguishments of debt, net	(1,520)		—		759		—		(761)
Acquisition related expenses	242		186		407		95		930

Warehouse redesign expenses(1)	157		176		51		18		402




Adjusted EBITDA(2)	$	10,681	$	19,693	$	21,469	$	7,689	$	59,532

(1) For the twelve months ended March 31, 2024, the warehouse redesign expenses were related to the U.S. segment.

(2) Adjusted EBITDA is a non-GAAP financial measure that is defined in the Company’s debt agreements. Adjusted EBITDA is defined as net (loss) income, adjusted to exclude undistributed equity in losses, income tax provision, interest expense, depreciation and amortization, mark to market (gain) loss on interest rate derivatives, stock compensation expense, (gain) loss on extinguishments of debt, net, and other items detailed in the table above that are consistent with exclusions permitted by our debt agreements.

Accounts Receivable Purchase Agreement

To improve its liquidity during seasonally high working capital periods, the Company has an uncommitted Receivables Purchase Agreement with HSBC Bank USA, National Association (“HSBC”) as Purchaser (the “Receivables Purchase Agreement”). Under the Receivables Purchase Agreement, the Company may offer to sell certain eligible accounts receivable (the “Receivables”) to HSBC, which may accept such offer, and purchase the offered Receivables. Under the Receivables Purchase Agreement, following each purchase of Receivables, the outstanding aggregate purchased Receivables shall not exceed $30.0 million. HSBC will assume the credit risk of the Receivables purchased, and the Company will continue to be responsible for all non-credit risk matters. The Company will service the Receivables, and as such servicer, collect and otherwise enforce the Receivables on behalf of HSBC. The term of the agreement is for 364 days and shall automatically be extended for annual successive terms unless terminated. Either party may terminate the agreement at any time upon sixty days’ prior written notice to the other party.

The Company did not sell receivables to HSBC during the three months ended March 31, 2024 and March 31, 2023. At March 31, 2024, $23.8 million of accounts receivables were available for sale to HSBC, net of applicable charges.

Derivatives

Interest Rate Swaps

- 37 -

Table of Contents

Foreign Exchange Contracts

Operating activities

Net cash provided by operating activities was $10.5 million for the three months ended March 31, 2024, as compared to net cash provided by operating activities of $12.1 million for the three months ended March 31, 2023. The decrease from 2024 compared to 2023 was attributable to higher use of cash related to inventory purchases, partially offset by timing of collections related to the Company's accounts receivables.

Investing activities

Net cash used in investing activities was $0.6 million and $0.5 million for the three months ended March 31, 2024 and 2023, respectively.

Financing activities

Net cash used in financing activities was $21.4 million for the three months ended March 31, 2024, as compared to net cash provided by financing activities of $5.7 million for the three months ended March 31, 2023. The change was attributable to the higher repayments of revolving credit facility in the 2024 period. The cash used in financing activities was partially offset by no payments for stock repurchases in the 2024 period.

Stock repurchase program

- 38 -

Table of Contents

Item 3. Quantitative and Qualitative Disclosures About Market Risk

There were no material changes in market risk for changes in foreign currency exchange rates and interest rates from the information provided in Item 7A – Quantitative and Qualitative Disclosures About Market Risk in the 2023 Annual Report on Form 10-K.

Item 4. Controls and Procedures

(a)Evaluation of Disclosure Controls and Procedures

The Chief Executive Officer and the Chief Financial Officer of the Company (its principal executive officer and principal financial officer, respectively) have concluded, based on their evaluation as of March 31, 2024, that the Company’s disclosure controls and procedures are effective to ensure that information required to be disclosed by the Company in the reports filed by it under the Securities and Exchange Act of 1934, as amended, is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission’s rules and forms, and include controls and procedures designed to ensure that information required to be disclosed by the Company in such reports is accumulated and communicated to the Company’s management, including the Chief Executive Officer and Chief Financial Officer of the Company, as appropriate to allow timely decisions regarding required disclosure.

(b)Changes in Internal Controls

There were no changes in the Company’s internal controls over financial reporting that occurred during the Company’s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the Company’s internal controls over financial reporting.

PART II - OTHER INFORMATION

Item 1. Legal Proceedings

For a description of the Company’s legal proceedings, please see NOTE 12 — CONTINGENCIES, to the Company's condensed consolidated financial statements included in this Quarterly Report on Form 10-Q.

Item 1A. Risk Factors

In addition to the other information set forth in this Quarterly Report on Form 10-Q, readers should carefully consider the factors discussed in Part I, Item 1A—Risk Factors in the 2023 Annual Report on Form 10-K, and in the Company’s other filings with the SEC, which could materially affect the Company’s business, financial condition, cash flows or future results. There have been no material changes from the risk factors previously disclosed in Part I, Item 1A—Risk Factors in the 2023 Annual Report on Form 10-K.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

Issuer Purchases of Equity Securities


Period	Total number of shares purchased(1)	Average price paid per share		Total number of shares purchased as part of publicly announced plans or programs(2)	Maximum approximate dollar value of shares that may yet be purchased under the plans or programs subsequent to end of period (2)


March 1 - March 31, 2024	105,359	$	9.76	—	$	11,140,752

(1)The repurchased shares were acquired other than as part of a publicly announced plan or program. The Company repurchased these securities in connection with its Amended and Restated 2000 Long Term Incentive Plan, which allows participants to use shares to satisfy the exercise price of options exercised, certain tax liabilities arising from the exercise of options, and certain tax liabilities arising from the vesting of restricted stock. The foregoing number does not include unvested shares forfeited back to the Company pursuant to the terms of its stock compensation plans.

(2)On March 14, 2022, the Company announced that its Board authorized the repurchase of up to $20.0 million of the Company’s common stock, replacing the Company’s previously-authorized $10 million share repurchase program. The repurchase authorization permits the Company to effect the repurchases from time to time through open market purchases and privately negotiated transactions. No repurchases occurred during the three months ended March 31, 2024.

- 39 -

Table of Contents

Item 5. Other Information

Rule 10b5-1 Trading Plans

None of the Company’s directors or officers adopted, modified, or terminated a Rule 10b5-1 trading arrangement or a non-Rule 10b5-1 trading arrangement during the Company’s fiscal quarter ended March 31, 2024.

- 40 -

Table of Contents

Item 6. Exhibits

See the Exhibit Index below, which is incorporated by reference herein.

Exhibit Index


Exhibit No.

10.1						Amendment No.4 to the Receivables Purchase Agreement, dated as of February 23, 2024 by and among the Company, as a Seller and as a Seller Agent and initial Servicer, for itself and each of its subsidiaries thereto as a Seller, and HSBC Bank USA, National Association, as Purchaser (incorporated by reference to Exhibit 10.51 to the C omp any's Annual Report on Form 10 -K for the year ended Dece mber 31, 2023)

31.1*						Certification by Robert B. Kay, Chief Executive Officer and Director, pursuant to Rule 13a-14(a) or Rule 15d-14(a) of the Securities and Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
31.2*						Certification by Laurence Winoker, Executive Vice President, Treasurer and Chief Financial Officer, pursuant to Rule 13a-14(a) or Rule 15d-14(a) of the Securities and Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

32.1**						Certification by Robert B. Kay, Chief Executive Officer and Director, and Laurence Winoker, Executive Vice President, Treasurer and Chief Financial Officer, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

101.INS*						Inline XBRL Instance Document (the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document)

101.SCH*						Inline XBRL Taxonomy Extension Schema Document

101.DEF*						Inline XBRL Taxonomy Extension Definition Linkbase Document

101.CAL*						Inline XBRL Taxonomy Extension Calculation Linkbase Document

101.LAB*						Inline XBRL Taxonomy Extension Labels Linkbase Document


101.PRE*						Inline XBRL Taxonomy Extension Presentation Linkbase Document
104						The cover page from this Quarterly Report on Form 10-Q, formatted in Inline XBRL and contained in Exhibit 101

* Filed herewith

** Furnished herewith

- 41 -

Table of Contents

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.


			Lifetime Brands, Inc.

			/s/ Robert B. Kay			May 9, 2024
			Robert B. Kay
			Chief Executive Officer and Director
			(Principal Executive Officer)

			/s/ Laurence Winoker			May 9, 2024
			Laurence Winoker
			Executive Vice President, Treasurer and Chief Financial Officer
			(Principal Financial and Accounting Officer)

- 42 -

Exhibit 31.1

CERTIFICATION

I, Robert B. Kay, certify that:

1.I have reviewed this quarterly report on Form 10-Q of Lifetime Brands, Inc. (“the registrant”);

2. Based on my knowledge, this quarterly report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this quarterly report;

3. Based on my knowledge, the financial statements, and other financial information included in this quarterly report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this quarterly report;

4. The registrant’s other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)4) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a.designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this quarterly report is being prepared;

b.designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c.evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d.disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter that has materially affected or is reasonably likely to materially affect the registrant’s internal control over financial reporting; and

1.The registrant’s other certifying officers and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a.all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b.any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.




/s/ Robert B. Kay
Robert B. Kay Chief Executive Officer and Director
Date: May 9, 2024

Exhibit 31.2

CERTIFICATION

I, Laurence Winoker, certify that:

1.I have reviewed this quarterly report on Form 10-Q of Lifetime Brands, Inc. (“the registrant”);

2.Based on my knowledge, this quarterly report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this quarterly report;

3.Based on my knowledge, the financial statements, and other financial information included in this quarterly report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this quarterly report;

4.The registrant’s other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)4) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

5.The registrant’s other certifying officers and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

b.any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.


/s/ Laurence Winoker
Laurence Winoker Executive Vice President, Treasurer and Chief Financial Officer

Date: May 9, 2024

Exhibit 32.1

Certification by Robert B. Kay, Chief Executive Officer and Director, and Laurence Winoker, Executive Vice President, Treasurer and Chief Financial Officer, Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

I, Robert B. Kay, Chief Executive Officer and Director, and I, Laurence Winoker, Executive Vice President, Treasurer and Chief Financial Officer, of Lifetime Brands, Inc., a Delaware corporation (the “Company”), each hereby certify that:

(1)The Company’s periodic report on Form 10-Q for the period ended March 31, 2024 (the “Form 10-Q”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

(2)The information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Company.


/s/ Robert B. Kay						/s/ Laurence Winoker
Robert B. Kay Chief Executive Officer and Director						Laurence Winoker Executive Vice President, Treasurer and Chief Financial Officer

Date: May 9, 2024						Date: May 9, 2024

A signed original of this certification required by 18 U.S.C. Section 1350 has been provided to Lifetime Brands, Inc. and will be retained by Lifetime Brands, Inc. and furnished to the SEC or its staff upon request.

Cover - shares	3 Months Ended
Cover - shares	Mar. 31, 2024	Apr. 30, 2024
Cover [Abstract]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Mar. 31, 2024
Document Transition Report	false
Entity File Number	0-19254
Entity Registrant Name	LIFETIME BRANDS, INC.
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	11-2682486
Entity Address, Address Line One	1000 Stewart Avenue
Entity Address, City or Town	Garden City
Entity Address, State or Province	NY
Entity Address, Postal Zip Code	11530
City Area Code	(516)
Local Phone Number	683-6000
Title of 12(b) Security	Common Stock, $.01 par value
Trading Symbol	LCUT
Security Exchange Name	NASDAQ
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		22,073,256
Amendment Flag	false
Document Fiscal Year Focus	2024
Document Fiscal Period Focus	Q1
Current Fiscal Year End Date	--12-31
Entity Central Index Key	0000874396

CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
CURRENT ASSETS
Cash and cash equivalents	$ 4,639	$ 16,189
Accounts receivable, less allowances of $15,177 at March 31, 2024 and $15,952 at December 31, 2023	113,645	155,180
Inventory	189,820	188,647
Prepaid expenses and other current assets	13,915	16,339
TOTAL CURRENT ASSETS	322,019	376,355
PROPERTY AND EQUIPMENT, net	16,356	16,970
OPERATING LEASE RIGHT-OF-USE ASSETS	66,662	69,756
INVESTMENTS	0	1,826
INTANGIBLE ASSETS, net	195,343	199,133
OTHER ASSETS	2,286	3,102
TOTAL ASSETS	602,666	667,142
CURRENT LIABILITIES
Current maturity of term loan	10,652	4,742
Accounts payable	32,855	54,154
Accrued expenses	64,697	78,356
Income taxes payable	567	641
Current portion of operating lease liabilities	14,251	14,075
TOTAL CURRENT LIABILITIES	123,022	151,968
OTHER LONG-TERM LIABILITIES	9,257	9,126
INCOME TAXES PAYABLE, LONG-TERM	1,493	1,493
OPERATING LEASE LIABILITIES	66,278	70,009
DEFERRED INCOME TAXES	7,429	7,438
REVOLVING CREDIT FACILITY	40,860	60,395
TERM LOAN	130,626	135,834
STOCKHOLDERS’ EQUITY
Preferred stock, $1.00 par value, shares authorized: 100 shares of Series A and 2,000,000 shares of Series B; none issued and outstanding	0	0
Common stock, $0.01 par value, shares authorized: 50,000,000 at March 31, 2024 and December 31, 2023; shares issued and outstanding: 22,073,256 at March 31, 2024 and 21,813,266 at December 31, 2023	221	218
Paid-in capital	277,496	277,728
Accumulated deficit	(20,771)	(13,568)
Accumulated other comprehensive loss	(33,245)	(33,499)
TOTAL STOCKHOLDERS’ EQUITY	223,701	230,879
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY	$ 602,666	$ 667,142

CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Accounts receivable, allowances	$ 15,177	$ 15,952
Common stock, par value (usd per share)	$ 0.01	$ 0.01
Common stock, shares authorized (in shares)	50,000,000	50,000,000
Common stock, shares issued (in shares)	22,073,256	21,813,266
Common stock, shares outstanding (in shares)	22,073,256	21,813,266
Preferred stock Series A
Preferred stock, par value (usd per share)	$ 1.00	$ 1.00
Preferred stock, shares authorized (in shares)	100	100
Preferred stock, issued (in shares)	0	0
Preferred stock, outstanding (in shares)	0	0
Preferred stock Series B
Preferred stock, par value (usd per share)	$ 1.00	$ 1.00
Preferred stock, shares authorized (in shares)	2,000,000	2,000,000
Preferred stock, issued (in shares)	0	0
Preferred stock, outstanding (in shares)	0	0

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Income Statement [Abstract]
Net sales	$ 142,242	$ 145,435
Cost of sales	84,695	91,593
Gross margin	57,547	53,842
Distribution expenses	16,181	16,885
Selling, general and administrative expenses	39,536	37,907
Restructuring expenses	0	856
Income (loss) from operations	1,830	(1,806)
Interest expense	(5,614)	(5,336)
Mark to market loss on interest rate derivatives	(174)	(234)
Loss before income taxes and equity in losses	(3,958)	(7,376)
Income tax (provision) benefit	(210)	1,348
Equity in losses, net of taxes	(2,092)	(2,777)
NET LOSS	$ (6,260)	$ (8,805)
Basic income (loss) per common share (usd per share)	$ (0.29)	$ (0.41)
Diluted income (loss) per common share (usd per share)	$ (0.29)	$ (0.41)

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Statement of Comprehensive Income [Abstract]
Net loss	$ (6,260)	$ (8,805)
Other comprehensive income, net of taxes:
Translation adjustment	40	1,561
Net change in cash flow hedges	201	(1,153)
Effect of retirement benefit obligations	13	12
Other comprehensive income, net of taxes	254	420
Comprehensive loss	$ (6,006)	$ (8,385)

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
shares in Thousands, $ in Thousands

Total

Common stock

Employee [Member]

Paid-in capital

Employee [Member]

Retained earnings (accumulated deficit)

Accumulated other comprehensive loss

Beginning Balance (in shares) at Dec. 31, 2022

21,780

Balance at beginning of year at Dec. 31, 2022

$ 240,088

$ 218

$ 274,579

$ 1,145

$ (35,854)

Comprehensive (loss) income:

Net loss

(8,805)

Other Comprehensive Income (Loss), Net of Tax

420

Performance shares issued to employees (in shares)

120

Performance shares issued to employees

$ 1

$ (1)

Net issuance of restricted shares to employees and directors (in shares)

185

Net issuance of restricted shares granted to employees

$ 2

(2)

Stock compensation expense

866

Shares effectively repurchased for required employee withholding taxes (in shares)

(74)

Shares effectively repurchased for required employee withholding taxes

(439)

$ (1)

(438)

Treasury Stock, Shares, Acquired

320

Stock Repurchased During Period, Value

2,539

$ 3

2,536

Dividends

(930)

Ending Balance (in shares) at Mar. 31, 2023

21,691

Balance at end of year at Mar. 31, 2023

228,661

^[1]

$ 217

275,004

(11,126)

^[1]

(35,434)

Beginning Balance (in shares) at Dec. 31, 2023

21,813

Balance at beginning of year at Dec. 31, 2023

230,879

$ 218

277,728

(13,568)

(33,499)

Comprehensive (loss) income:

Net loss

(6,260)

Other Comprehensive Income (Loss), Net of Tax

254

Performance shares issued to employees (in shares)

152

Performance shares issued to employees

$ 2

(2)

Net issuance of restricted shares to employees and directors (in shares)

213

Net issuance of restricted shares granted to employees

$ 2

$ (2)

Stock compensation expense

799

Shares effectively repurchased for required employee withholding taxes (in shares)

(105)

Shares effectively repurchased for required employee withholding taxes

(1,028)

$ (1)

(1,027)

Dividends

(943)

Ending Balance (in shares) at Mar. 31, 2024

22,073

Balance at end of year at Mar. 31, 2024

$ 223,701

$ 221

$ 277,496

$ (20,771)

$ (33,245)

[1]	Cash dividends declared per share of common stock were $0.0425 and $0.0425 in the three months ended March 31, 2024 and 2023, respectively.

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (Parenthetical) - $ / shares		3 Months Ended
	Mar. 08, 2024	Mar. 31, 2024	Mar. 31, 2023
Statement of Stockholders' Equity [Abstract]
Dividend per share of common stock (usd per share)	$ 0.0425	$ 0.0425	$ 0.0425

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
OPERATING ACTIVITIES
Net loss	$ (6,260)	$ (8,805)
Adjustments to reconcile net loss to net cash provided by operating activities:
Depreciation and amortization	4,939	4,870
Amortization of financing costs	739	477
Mark to market loss on interest rate derivatives	174	234
Non-cash lease adjustment	(455)	(713)
Provision for doubtful accounts	195	1,643
Stock compensation expense	807	861
Undistributed losses from equity investment, net of taxes	2,092	2,777
Changes in operating assets and liabilities
Accounts receivable	41,119	15,336
Inventory	(1,566)	13,368
Prepaid expenses, other current assets and other assets	3,159	1,811
Accounts payable, accrued expenses and other liabilities	(34,359)	(18,085)
Income taxes receivable	0	(1,434)
Income taxes payable	(71)	(235)
NET CASH PROVIDED BY OPERATING ACTIVITIES	10,513	12,105
INVESTING ACTIVITIES
Purchases of property and equipment	(600)	(511)
NET CASH USED IN INVESTING ACTIVITIES	(600)	(511)
FINANCING ACTIVITIES
Payments for finance lease obligations	(7)	(7)
Payments of tax withholding for stock based compensation	(1,028)	(439)
Payments for stock repurchase	0	(2,539)
Cash dividends paid	(1,026)	(985)
NET CASH (USED IN) PROVIDED BY FINANCING ACTIVITIES	(21,399)	5,707
Effect of foreign exchange on cash	(64)	59
(DECREASE) INCREASE IN CASH AND CASH EQUIVALENTS	(11,550)	17,360
Cash and cash equivalents at beginning of period	16,189	23,598
CASH AND CASH EQUIVALENTS AT END OF PERIOD	4,639	40,958
Revolving Credit Facility
FINANCING ACTIVITIES
Proceeds from revolving credit facility	51,484	18,357
Repayments of Long-Term Lines of Credit	$ (70,822)	$ (8,680)

BASIS OF PRESENTATION AND SUMMARY OF ACCOUNTING POLICIES

3 Months Ended

Mar. 31, 2024

Accounting Policies [Abstract]

BASIS OF PRESENTATION AND SUMMARY OF ACCOUNTING POLICIES

Organization and business

Basis of presentation

Operating results for the three months ended March 31, 2024 are not necessarily indicative of the results that may be expected for the year ending December 31, 2024.

Revenue recognition

Cost of sales

Cost of sales consist primarily of costs associated with the production and procurement of product, inbound freight costs, purchasing costs, royalties, and other product procurement related charges.

Distribution expenses

Distribution expenses consist primarily of warehousing expenses and freight-out expenses. Handling costs of products sold are included in cost of sales.

Accounts receivable

Receivable purchase agreement

At March 31, 2024, $23.8 million of accounts receivables were available for sale to HSBC, net of applicable charges.

Inventory

The components of inventory were as follows (in thousands):


	March 31, 2024		December 31, 2023
Finished goods	$	181,627	$	180,860
Work in process	164		106
Raw materials	8,029		7,681
Total	$	189,820	$	188,647

Fair value of financial instruments

Derivatives

Goodwill, intangible assets and long-lived assets

See NOTE 5 — INTANGIBLE ASSETS to the unaudited condensed consolidated financial statements included in this Quarterly Report on Form 10-Q for additional information.

Leases

Employee healthcare

Restructuring expenses

New accounting pronouncements

REVENUE

3 Months Ended

Mar. 31, 2024

Revenue from Contract with Customer [Abstract]

REVENUE

consideration are constrained. Payment terms vary by customer, but generally range from 30 to 90 days or at the point of sale for the Company’s retail direct sales.

The following tables present the Company’s net sales disaggregated by segment, product category and geographic region for the three months ended March 31, 2024 and 2023 (in thousands):


	Three Months Ended
	March 31,
	2024		2023
U.S. segment
Kitchenware	$	83,530	$	85,732
Tableware	25,759		23,999
Home Solutions	21,191		23,754
Total U.S. segment	130,480		133,485



International segment	11,762		11,950
Total net sales	$	142,242	$	145,435

United States	$	120,503	$	127,246
United Kingdom	7,466		8,612
Rest of World	14,273		9,577
Total net sales	$	142,242	$	145,435

LEASES

3 Months Ended

Mar. 31, 2024

Leases [Abstract]

LEASES

The Company has operating leases for corporate offices, distribution facilities, a manufacturing plant, and certain vehicles.

The components of lease expense for the three months ended March 31, 2024 and 2023 were as follows (in thousands):


	Three Months Ended March 31,
	2024		2023
Operating lease expenses(1):
Fixed lease expense	$	4,263	$	4,174
Variable lease expense	1,368		1,426
Total	$	5,631	$	5,600

(1) Expenses are recorded within distribution expenses and selling, general and administrative expenses on the unaudited condensed consolidated statement of operations.

Supplemental cash flow information for lease related liabilities and assets for the three months ended March 31, 2024 and 2023 were as follows (in thousands):


	Three Months Ended March 31,
	2024		2023
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows for operating leases	$	4,718	$	4,887


	Three Months Ended March 31,
	2024		2023
Right-of-use assets obtained in exchange for lease obligations:
Operating leases	$	—	$	1,184

The aggregate future lease payments for operating leases as of March 31, 2024 were as follows (in thousands):


	Operating
2024 (excluding the three months ended March 31, 2024)	$	14,231
2025	18,721
2026	18,348
2027	14,219
2028	12,824
2029	6,678
Thereafter	11,749
Total lease payments	96,770
Less: Interest	(16,241)
Present value of lease payments	$	80,529

Average lease terms and discount rates were as follows:


	March 31, 2024
Operating leases:
Weighted-average remaining lease term (years)	5.7
Weighted-average discount rate	6.4	%

INVESTMENTS

3 Months Ended

Mar. 31, 2024

Equity Method Investments and Joint Ventures [Abstract]

INVESTMENTS

The Company’s equity in losses, net of taxes, for the three months ended March 31, 2024 and 2023 included the following:


	Three Months Ended March 31,
	2024		2023
Vasconia equity in losses, net of taxes	$	(2,092)	$	(724)
Impairment on investment in Vasconia	—		(2,053)
Equity in losses, net of taxes	$	(2,092)	$	(2,777)

INTANGIBLE ASSETS

3 Months Ended

Mar. 31, 2024

Goodwill and Intangible Assets Disclosure [Abstract]

INTANGIBLE ASSETS

Intangible assets consisted of the following as of March 31, 2024 and December 31, 2023 (in thousands):


	March 31, 2024				December 31, 2023
	Gross		Accumulated Amortization		Net		Gross		Accumulated Amortization		Net
Goodwill(1)	$	33,237	$	—	$	33,237	$	33,237	$	—	$	33,237
Indefinite-lived intangible assets:
Trade names(1)	42,000		—		42,000		42,000		—		42,000
Finite-lived intangible assets:
Licenses	15,847		(12,224)		3,623		15,847		(12,110)		3,737
Trade names(2)	62,475		(24,896)		37,579		62,493		(23,862)		38,631
Customer relationships(2)	143,157		(66,124)		77,033		143,158		(63,630)		79,528
Other (2)	5,870		(3,999)		1,871		5,872		(3,872)		2,000
Total	$	302,586	$	(107,243)	$	195,343	$	302,607	$	(103,474)	$	199,133

DEBT

3 Months Ended

Mar. 31, 2024

Debt Disclosure [Abstract]

DEBT

Agreement provides for a senior secured asset-based revolving credit facility in the maximum aggregate principal amount of $200.0 million, which facility will mature on August 26, 2027.

As of March 31, 2024 and December 31, 2023, the total availability under the ABL Agreement were as follows (in thousands):


	March 31, 2024		December 31, 2023
Maximum aggregate principal allowed	$	146,084	$	181,919
Outstanding borrowings under the ABL Agreement	(40,860)		(60,395)
Standby letters of credit	(8,522)		(2,894)
Total availability under the ABL Agreement	$	96,702	$	118,630

The current and non-current portions of the Company’s Term Loan included in the condensed consolidated balance sheets were as follows (in thousands):


	March 31, 2024		December 31, 2023
Current portion of Term Loan:
Term Loan payment	$	9,375	$	7,500
Estimated Excess Cash Flow principal payment	4,000		—
Estimated unamortized debt issuance costs	(2,723)		(2,758)
Total Current portion of Term Loan	$	10,652	$	4,742

Non-current portion of Term Loan:
Term Loan, net of current portion	$	136,625	$	142,500
Estimated unamortized debt issuance costs	(5,999)		(6,666)
Total Non-current portion of Term Loan	$	130,626	$	135,834

The Company was in compliance with the covenants of the Debt Agreements at March 31, 2024.

The Company expects that it will continue to borrow, subject to availability, and repay funds under the ABL Agreement based on working capital and other corporate needs

DERIVATIVES

3 Months Ended

Mar. 31, 2024

Derivative Instruments and Hedging Activities Disclosure [Abstract]

DERIVATIVES

Interest Rate Swap Agreements

Foreign Exchange Contracts

not enter into such contracts for speculative purposes, and as of March 31, 2024, these foreign exchange contracts have been designated as hedges in to order to apply hedge accounting.

The fair values of the Company’s derivative financial instruments included in the condensed consolidated balance sheets are presented as follows (in thousands):


Derivatives designated as hedging instruments	Balance Sheet Location	March 31, 2024		December 31, 2023




Foreign exchange contracts	Prepaid expenses and other current assets	$	67	$	56

	Accrued expenses	73		144


Derivatives not designated as hedging instruments	Balance Sheet Location	March 31, 2024		December 31, 2023
Interest rate swaps	Prepaid expenses and other current assets	$	722	$	—
	Other assets	—		793
	Other long-term liabilities	104		—


	Three Months Ended March 31,
Derivatives designated as hedging instruments	2024		2023
Interest rate swaps	$	—	$	(120)
Foreign exchange contracts	201		(1,033)
	$	201	$	(1,153)

Realized gains and losses on foreign exchange contracts that are reported in other comprehensive income are reclassified into cost of sales as the underlying inventory purchased is sold.

Interest and mark to market (losses) related to the Company’s derivative financial instruments not designated as hedging instruments that were recognized in earnings are as follows (in thousands):


		Three Months Ended March 31,
Derivatives not designated as hedging instruments	Location of gain (loss)	2024		2023
Interest rate swaps	Mark to market (loss) on interest rate derivatives	$	(174)	$	(234)
	Interest expense	221		165
		$	47	$	(69)

STOCK COMPENSATION

3 Months Ended

Mar. 31, 2024

Share-Based Payment Arrangement [Abstract]

STOCK COMPENSATION

Option Awards

A summary of the Company’s stock option activity and related information for the three months ended March 31, 2024 is as follows:


	Options		Weighted- average exercise price		Weighted- average remaining contractual life (years)	Aggregate intrinsic value (in thousands)
Options outstanding, January 1, 2024	999,500		$	13.31
Grants	50,000		9.76


Expirations	(100,000)		18.04
Options outstanding, March 31, 2024	949,500		12.63		4.6	$	742
Options exercisable, March 31, 2024	806,875		$	13.21	3.8	$	506
Total unrecognized stock option expense remaining (in thousands)	$	556
Weighted-average years expected to be recognized over	1.9

Restricted Stock

A summary of the Company’s restricted stock activity and related information for the three months ended March 31, 2024 is as follows:


	Restricted Shares		Weighted- average grant date fair value
Non-vested restricted shares, January 1, 2024	597,528		$	8.44
Grants	219,975		9.76
Vested	(140,060)		10.67
Cancellations	(6,814)		10.39
Non-vested restricted shares, March 31, 2024	670,629		$	8.38
Total unrecognized compensation expense remaining (in thousands)	$	4,857
Weighted-average years expected to be recognized over	1.9

The total fair value of restricted stock that vested during the three months ended March 31, 2024 was $1.4 million.

Performance shares

A summary of the Company’s performance-based award activity and related information for the three months ended March 31, 2024 is as follows:


	Performance- based stock awards (1)		Weighted- average grant date fair value
Non-vested performance-based awards, January 1, 2024	486,972		$	10.44
Grants	219,975		9.76

Vested	(152,188)		14.18
Cancellations	(23,047)		13.54
Non-vested performance-based awards, March 31, 2024	531,712		$	8.96
Total unrecognized compensation expense remaining (in thousands)(2)	$	2,720
Weighted-average years expected to be recognized over	2.5

(1)Represents the target number of shares to be issued for each performance-based award.

(2)The performance metric for the performance-based awards granted in 2022 is not probable of achievement. Therefore, no compensation expense has been recorded on these awards.

The total fair value of performance-based awards that vested during the three months ended March 31, 2024 was $1.5 million.

Cash-settled performance-based awards

A summary of the Company’s cash-settled performance-based awards activity and related information for the three months ended March 31, 2024 is as follows:


	Cash-settled performance-based awards (1)		Weighted- average fair value
Non-vested cash-settled performance-based awards, January 1, 2024	83,611		$	6.71


Cancellations	(1,107)		10.14
Non-vested cash-settled performance-based awards, March 31, 2024	82,504		$	10.48
Total unrecognized compensation expense remaining (in thousands)(2)	$	—
Weighted-average years expected to be recognized over	0.0

(1) Represents the target number of units to be settled in cash.

(2) The performance metric for the cash-settled performance-based awards granted in 2022 is not probable of achievement. Therefore, no compensation expense has been recorded on these awards.

The Company recorded stock compensation expense as follows (in thousands):


	Three Months Ended March 31,
Stock Compensation Expense Components	2024		2023
Equity based stock option expense	$	50	$	129
Restricted and performance-based stock awards expense	749		737
Stock compensation expense for equity based awards	$	799	$	866
Liability based stock option expense	8		(5)

Total Stock Compensation Expense	$	807	$	861

INCOME (LOSS) PER COMMON SHARE

3 Months Ended

Mar. 31, 2024

Earnings Per Share [Abstract]

INCOME (LOSS) PER COMMON SHARE

LOSS PER COMMON SHARE

The calculations of basic and diluted loss per common share for the three months ended March 31, 2024 and 2023 are as follows:


	Three Months Ended March 31,
	2024		2023
	(in thousands, except per share amounts)
Net loss – Basic and Diluted	$	(6,260)	$	(8,805)
Weighted-average shares outstanding – Basic	21,377		21,225
Effect of dilutive securities:
Stock options and other stock awards	—		—
Weighted-average shares outstanding – Diluted	21,377		21,225
Basic loss per common share	$	(0.29)	$	(0.41)
Diluted loss per common share	$	(0.29)	$	(0.41)
Antidilutive Securities(1)	1,605		1,581

(1) Stock options and other stock awards that have been excluded from the denominator as their inclusion would have been anti-dilutive.

INCOME TAXES	3 Months Ended
INCOME TAXES	Mar. 31, 2024
Income Tax Disclosure [Abstract]
INCOME TAXES	INCOME TAXES Income tax provision of $0.2 million and income tax benefit of $1.3 million for the three months ended March 31, 2024 and 2023, respectively, represent taxes on both U.S. and foreign earnings at a combined effective income tax provision rate of (5.3)% and benefit rate of 18.3%, respectively. The negative rate for the three months ended March 31, 2024 reflects tax expense on a pretax financial reporting loss. The effective tax rate for the three months ended March 31, 2024 differs from the federal statutory income tax rate of 21.0% primarily due to the expiration of non-qualified stock options and the vesting of equity-based awards, where the book expense exceeded the tax deduction upon vesting, and foreign losses for which no tax benefit is recognized as such amounts are fully offset with a valuation allowance. The effective tax rate for the three months ended March 31, 2023 differs from the federal statutory income tax rate of 21.0% primarily due to state and local tax expense, the impact of non-deductible expenses, and foreign losses for which no tax benefit is recognized as such amounts are fully offset with a valuation allowance. The Company has identified the following jurisdictions as “major” tax jurisdictions: U.S. Federal, California, Massachusetts, New Jersey, New York and the United Kingdom. The Company evaluates its tax positions on a quarterly basis and revises its estimates accordingly. There were no material changes to the Company’s uncertain tax positions, interest, or penalties during the three-month periods ended March 31, 2024 and March 31, 2023.

BUSINESS SEGMENTS

3 Months Ended

Mar. 31, 2024

Segment Reporting [Abstract]

BUSINESS SEGMENTS


	Three Months Ended March 31,
	2024		2023
	(in thousands)
Net sales
U.S.	$	130,480	$	133,485
International	11,762		11,950
Total net sales	$	142,242	$	145,435
Income (loss) from operations
U.S.	$	9,442	$	5,954
International	(3,089)		(1,892)
Unallocated corporate expenses	(4,523)		(5,868)
Income (loss) from operations	$	1,830	$	(1,806)
Depreciation and amortization
U.S.	$	4,656	$	4,618
International	283		252
Total depreciation and amortization	$	4,939	$	4,870


	March 31, 2024		December 31, 2023
	(in thousands)
Assets
U.S.	$	518,377	$	560,716
International	79,650		90,237
Unallocated corporate	4,639		16,189
Total Assets	$	602,666	$	667,142

CONTINGENCIES	3 Months Ended
CONTINGENCIES	Mar. 31, 2024
Commitments and Contingencies Disclosure [Abstract]
CONTINGENCIES	CONTINGENCIES Wallace EPA Matter Wallace Silversmiths de Puerto Rico, Ltd. (“WSPR”), a wholly-owned subsidiary of the Company, operates a manufacturing facility in San Germán, Puerto Rico that is leased from the Puerto Rico Industrial Development Company (“PRIDCO”). In March 2008, the U.S. Environmental Protection Agency (the “EPA”) announced that the San Germán Ground Water Contamination site in Puerto Rico (the “Site”) had been added to the Superfund National Priorities List due to contamination present in the local drinking water supply. In May 2008, WSPR received from the EPA a Notice of Potential Liability and Request for Information pursuant to 42 U.S.C. Sections 9607(a) and 9604(e) of the Comprehensive Environmental Response, Compensation, and Liability Act (“CERCLA”). In July 2011, WSPR received a letter from the EPA requesting access to the property that it leases from PRIDCO to conduct an environmental investigation, and the Company granted such access. In February 2013, the EPA requested access to conduct a further environmental investigation at the property. PRIDCO agreed to such access and the Company consented. The EPA conducted a further investigation during 2013 and, in April 2015, notified the Company and PRIDCO that the results from vapor intrusion sampling may warrant the implementation of measures to mitigate potential exposure to sub-slab soil gas. The Company reviewed the information provided by the EPA and requested that PRIDCO, as the property owner, find and implement a solution acceptable to the EPA. While WSPR did not cause the sub-surface condition that resulted in the potential for vapor intrusion, in order to protect the health of its employees and continue its business operations, it has nevertheless implemented corrective action measures to prevent vapor intrusion, such as sealing the floors of the building and conducting periodic air monitoring to address potential exposure. On August 13, 2015, the EPA released its remedial investigation and feasibility study (“RI/FS”) for the Site. On December 11, 2015, the EPA issued the Record of Decision (“ROD”) for an initial operable unit (“OU-1”), electing to implement its preferred remedy which consists of soil vapor extraction and dual-phase extraction/in-situ treatment. This selected remedy includes soil vapor extraction (“SVE”) to address soil (vadose zone) source areas at the Site, impermeable cover as necessary for the implementation of SVE, dual phase extraction in the shallow saprolite zone, and in-situ treatment as needed to address residual sources. The EPA’s total net present worth estimated cost for its selected remedy is $7.3 million. In February 2017, the EPA indicated that it planned to expand its field investigation for the RI/FS to a second operable unit (“OU-2”) to determine the nature and extent of the groundwater contamination at and from the Site and to determine the nature of the remedial action needed to address the contamination. The EPA requested access to the property occupied by WSPR to install monitoring wells and to undertake groundwater sampling as part of this expanded investigation. WSPR consented to the EPA’s access request, provided that the EPA received PRIDCO’s consent as the property owner. WSPR never used the primary contaminant of concern and did not take up its tenancy at the Site until after the EPA had discovered the contamination in the local water supply. The EPA has also issued notices of potential liability to a number of other entities affiliated with the Site, which used the contaminants of concern. In December 2018, the Company, WSPR, and other identified potentially responsible parties affiliated with the Site entered into tolling agreements with the U.S. government to extend the statute of limitations for potential claims for the recovery of response costs for the initial operable unit under Section 107 of CERCLA. The tolling agreements have been extended multiple times and currently expire in November 2025. The tolling agreements do not constitute in any way an admission or acknowledgment of any fact, conclusion of law, or liability by the parties to the agreements. The EPA released its proposed plan for OU-2 in July 2019, and on September 30, 2019, the EPA issued the ROD for OU-2. The EPA elected to implement its preferred remedy consisting of in-situ treatment of groundwater and a monitored natural attenuation program including monitoring of the plume fringe at the Site. The EPA’s estimated total net present worth cost for its selected remedy for OU-2 is $17.3 million, and the EPA is currently leading remediation of OU-2. In August 2021, WSPR received a Notice of Liability for the Site from the Department of Justice on behalf of the EPA, and in September 2021, WSPR responded with a good faith offer to conduct additional testing and remedial design work for OU-1. WSPR has actively participated in negotiations among the U.S. Government (the Department of Justice and the EPA) and other potentially responsible parties with respect to the remedial work at OU-1, which negotiations culminated in the finalization of a Consent Decree for Remedial Design and Remedial Action at Operable Unit One of the San German Groundwater Contamination Site (“Consent Decree”). On July 26, 2023, the U.S. Government filed a complaint in United States District Court for the District of Puerto Rico for the purpose of seeking judicial approval of the Consent Decree. As required by applicable regulations, the U.S. Government simultaneously lodged the Consent Decree for public comment. No comments were received during the public comment period. On September 6, 2023, at the conclusion of the public comment period, the U.S. Government filed a Motion to Enter the Consent Decree, which the court granted on December 1, 2023, thereby effectuating the Consent Decree. The Company has reserved $5.6 million to cover probable and estimable liabilities with respect to the above remedial design and remedial action for the initial operable unit. However, it is not possible at this time for the Company to estimate its share of its ultimate liability for the Site. In the event of one or more adverse determinations related to this matter, it is possible that the ultimate liability resulting from this matter and the impact on the Company’s results of operations could be material. U.S. Customs and Border Protection matter By letter dated August 26, 2019, the Company was advised that U.S. Customs and Border Protection ("CBP") had commenced an investigation, pursuant to 19 U.S.C. §1592, regarding the Company’s tariff classification of certain tableware and kitchenware. The issue centers on whether such merchandise meets the criteria for reduced duty rates as specified sets as those terms are defined in Chapter 69, Note 6(b), Harmonized Tariff System of the United States. The period of investigation is stated to be from August 26, 2014 to the present. Since being notified of the investigation, the Company has obtained a significant amount of evidence that, the Company believes, supports that the imported products were properly classified as specified sets. The Company's counsel filed a Lead Protest and Application for Further Review with CBP on February 5, 2020 (the "Lead Protest") relating to a single shipment made during the investigation period. CBP approved the Company’s Lead Protest on June 8, 2020 stating that the specified set requirement was fulfilled with respect to the protested shipment based on information provided by the Company. Based on this decision, no additional duties will be owed for the seven tableware collections imported in this shipment. The Company also compiled and submitted to CBP a complete set of supporting documents for three additional protests (for the remaining 29 tableware collections that were imported by the Company under the protested shipments). One of the additional protests was approved on October 15, 2020; the other two remain pending. If the CBP approves these additional claims and accepts the evidence presented, then no additional duties will be owed for the remaining protested shipments. Because the period of investigation covers a five-year period, the Company is compiling supporting documentation packages for all tableware collections imported during this period. In the event CBP accepts the evidence presented, then no additional duties or penalties will be owed. If CBP rejects the Company’s position, then the estimated amount of duties that could be owed is $0.3 million. In such event, it is reasonably possible that additional penalties could be assessed, depending upon the level of culpability found, of up to $0.6 million for negligence and up to $1.2 million for gross negligence. In the event penalties are assessed, the Company will have the opportunity to further contest CBP’s findings and seek cancellation or mitigation of such assessments. Accordingly, based on the above uncertainties and variables, the Company considers the potential losses related to this matter to be reasonably possible, but not probable. However, in the event of one or more adverse determinations related to this matter, it is possible that the ultimate liability resulting from this matter and the impact on the Company’s results of operations could be material. Other The Company is, from time to time, involved in other legal proceedings. The Company believes that other current litigation is routine in nature and incidental to the conduct of the Company’s business and that none of this litigation, individually or collectively, would have a material adverse effect on the Company’s consolidated financial position, results of operations or cash flows.

OTHER

3 Months Ended

Mar. 31, 2024

Organization, Consolidation and Presentation of Financial Statements [Abstract]

OTHER

Cash dividends

Dividends declared in the three months ended March 31, 2024 were as follows:

Dividend per share

Date declared

Date of record

Payment date

$0.0425

3/8/2024

5/1/2024

5/15/2024

In the three months ended March 31, 2024, the Company reduced retained earnings for the accrual of $0.9 million relating to the dividend payable on May 15, 2024.

Stock repurchase program

Supplemental cash flow information


	Three Months Ended March 31,
	2024		2023
	(in thousands)
Supplemental disclosure of cash flow information:
Cash paid for interest	$	5,105	$	5,104
Cash paid for taxes, net of refunds	282		320

Components of accumulated other comprehensive loss, net


	Three Months Ended March 31,
	2024		2023
	(in thousands)
Accumulated translation adjustment:
Balance at beginning of period	$	(32,614)	$	(36,072)
Translation adjustment during period	40		1,561


Balance at end of period	$	(32,574)	$	(34,511)
Accumulated deferred gains (losses) on cash flow hedges:
Balance at beginning of period	$	(134)	$	923
Change in unrealized gains (losses)	70		(250)
Amounts reclassified from accumulated other comprehensive loss:
Settlement of cash flow hedge (1)	131		(903)
Net change in cash flow hedges, net of taxes of $0, $(2)	201		(1,153)
Balance at end of period	$	67	$	(230)
Accumulated effect of retirement benefit obligations:
Balance at beginning of period	$	(751)	$	(705)
Amounts reclassified from accumulated other comprehensive loss: (2)
Amortization of actuarial loss, net of taxes of $(4), $(4)	13		12
Balance at end of period	$	(738)	$	(693)
Total accumulated other comprehensive loss at end of period	$	(33,245)	$	(35,434)

(1)Amounts reclassified are recorded in interest expense and cost of sales on the unaudited condensed consolidated statement of operations.

(2)Amounts are recorded in selling, general and administrative expense on the unaudited condensed consolidated statements of operations.

Pay vs Performance Disclosure - USD ($) $ in Thousands	3 Months Ended
Pay vs Performance Disclosure - USD ($) $ in Thousands	Mar. 31, 2024	Mar. 31, 2023
Pay vs Performance Disclosure
Net loss	$ (6,260)	$ (8,805)

Insider Trading Arrangements	3 Months Ended
Insider Trading Arrangements	Mar. 31, 2024
Trading Arrangements, by Individual
Rule 10b5-1 Arrangement Adopted	false

BASIS OF PRESENTATION AND SUMMARY OF ACCOUNTING POLICIES (Policies)	3 Months Ended
	Mar. 31, 2024
Accounting Policies [Abstract]
Basis of presentation	Basis of presentation The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles (“U.S. GAAP”) for interim financial information and with the instructions to Quarterly Reports on Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements. In the opinion of management, all adjustments, which consist of normal recurring accruals and non-recurring adjustments, considered necessary for a fair presentation have been included. These condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and footnotes thereto included in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2023. Operating results for the three months ended March 31, 2024 are not necessarily indicative of the results that may be expected for the year ending December 31, 2024. The Company’s business and working capital needs are seasonal, with a majority of sales occurring in the third and fourth quarters. In 2023 and 2022, net sales for the third and fourth quarters accounted for 57% and 54% of total annual net sales, respectively. In anticipation of the pre-holiday shipping season, inventory levels increase primarily in the June through October time period. The Company’s current estimates contemplate current and expected future conditions, as applicable, however it is reasonably possible that actual conditions could differ from expectations, which could materially affect the Company’s results of operations and financial position.
Revenue recognition and Cost of sales	Revenue recognition The Company sells products wholesale, to retailers and distributors, and retail, directly to the consumer. Wholesale sales and retail sales are primarily recognized at the point in time the customer obtains control of the products, in an amount that reflects the consideration the Company expects to be entitled to in exchange for those products. The Company offers various sales incentives and promotional programs to its customers in the normal course of business. These incentives and promotions typically include arrangements such as cooperative advertising, buydowns, volume rebates and discounts. These arrangements and an estimate for products expected to be returned are reflected as reductions of revenue at the time of sale. See NOTE 2 —REVENUE to the unaudited condensed consolidated financial statements included in this Quarterly Report on Form 10-Q for additional information. Cost of sales Cost of sales consist primarily of costs associated with the production and procurement of product, inbound freight costs, purchasing costs, royalties, and other product procurement related charges.
Distribution expenses	Distribution expenses Distribution expenses consist primarily of warehousing expenses and freight-out expenses. Handling costs of products sold are included in cost of sales.
Accounts receivable	Accounts receivable The Company periodically reviews the collectability of its accounts receivable and establishes allowances for estimated credit losses that could result from the inability of its customers to make required payments, taking into consideration customer credit history and financial condition, industry and market segment information, credit reports, and expectations of current and future economic conditions. A considerable amount of judgment is required to assess the ultimate realization of these receivables, including assessing the initial and on-going creditworthiness of the Company’s customers. The Company also maintains an allowance for anticipated customer deductions. The allowances for deductions are primarily based on contracts with customers. However, in certain cases, the Company does not have a formal contract and, therefore, customer deductions are non-contractual. To evaluate the reasonableness of non-contractual customer deductions, the Company analyzes currently available information and historical trends of deductions.
Receivable purchase agreement	Receivable purchase agreement The Company has an uncommitted Receivables Purchase Agreement with HSBC Bank USA, National Association (“HSBC”) as Purchaser (the “Receivables Purchase Agreement”). The sale of accounts receivable, under the Receivables Purchase Agreement with HSBC, is excluded from the Company’s unaudited condensed consolidated balance sheets at the time of sale and the related sale expense is included in selling, general and administrative expenses in the Company’s unaudited condensed consolidated statements of operations. The Company did not sell receivables to HSBC during the three months ended March 31, 2024 and March 31, 2023. At March 31, 2024, $23.8 million of accounts receivables were available for sale to HSBC, net of applicable charges.
Inventory	Inventory Inventory consists principally of finished goods sourced from third-party suppliers. Inventory also includes finished goods, work in process and raw materials related to the Company’s manufacture of sterling silver products. Inventory is priced using the lower of cost (first-in, first-out basis) or net realizable value. The Company estimates the selling price of its inventory on a product-by-product basis based on the current selling environment. If the estimated selling price is lower than the inventory’s cost, the Company reduces the value of the inventory to its net realizable value. Net realizable value is the estimated selling price in the ordinary course of business, less reasonably predictable cost of completion, disposal and transportation.
Fair value of financial instruments	Fair value of financial instruments The Company determined that the carrying amounts of cash and cash equivalents, accounts receivable and accounts payable are reasonable estimates of their fair values because of their short-term nature. The Company determined that the carrying amounts of borrowings outstanding under its ABL Agreement and Term Loan (each as defined in NOTE 6 — DEBT to the unaudited condensed consolidated financial statements included in this Quarterly Report on Form 10-Q) approximate fair value since such borrowings bear interest at variable market rates.
Derivatives	Derivatives The Company accounts for derivative instruments in accordance with Accounting Standard Codification (“ASC”) Topic 815, Derivatives and Hedging (“ASC 815”). ASC 815 requires that all derivative instruments be recognized on the balance sheet at fair value as either an asset or liability. Changes in the fair value of derivatives that qualify as hedges and have been designated as part of a hedging relationship for accounting purposes have no net impact on earnings until the hedged item is recognized in earnings. The changes in the fair value of hedges are included in accumulated other comprehensive loss and are subsequently recognized in the Company’s unaudited condensed consolidated statements of operations to mirror the location of the hedged items impacting earnings. Changes in fair value of derivatives that do not qualify as hedging instruments for accounting purposes are recorded in the Company’s unaudited condensed consolidated statements of operations.
Goodwill, intangible assets and long-lived assets	Goodwill, intangible assets and long-lived assets Goodwill and intangible assets deemed to have indefinite lives are not amortized but, instead, are subject to an annual impairment assessment. Additionally, if events or conditions were to indicate the carrying value of a reporting unit may not be recoverable, the Company would evaluate goodwill and other intangible assets for impairment at that time. As it relates to the goodwill assessment, the Company first assesses qualitative factors to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying amount as a basis for determining whether it is necessary to perform the quantitative goodwill impairment testing described in the Financial Accounting Standards Board's (“FASB”) Accounting Standards Update No. (“ASU”) Topic 350, Intangibles – Goodwill and Other. If, after assessing qualitative factors, the Company determines that it is not more likely than not that the fair value of a reporting unit is less than its carrying amount, then performing the quantitative test is unnecessary and the Company’s goodwill is considered to be unimpaired. However, if based on the Company’s qualitative assessment it concludes that it is more likely than not that the fair value of the reporting unit is less than its carrying amount, or if the Company elects to bypass the qualitative assessment, the Company will proceed with performing the quantitative impairment test. The Company reviews goodwill and other intangibles that have indefinite lives for impairment annually as of October 1 or when events or changes in circumstances indicate the carrying value of these assets might exceed their current fair values. Impairment testing is based upon the best information available, including estimates of fair value which incorporate assumptions marketplace participants would use in making their estimates of fair value. The Company performed its annual impairment assessment of its U.S. reporting unit as of October 1, 2023 by comparing the fair value of the reporting unit with its carrying value. The Company performed the analysis using a discounted cash flow and market multiple method. As of October 1, 2023, the fair value of the U.S. reporting unit exceeded the carrying value of goodwill by 4%. The significant assumptions used under the income approach, or discounted cash flow method, are projected net sales, projected earnings before interest, tax, depreciation and amortization (“EBITDA”) and the cost of capital. Projected net sales and projected EBITDA were determined to be significant assumptions because they are the primary drivers of the projected cash flows in the discounted cash flow fair value model. Cost of capital was also determined to be a significant assumption as it is the discount rate used to calculate the current fair value of those projected cash flows. Although the Company believes the assumptions and estimates made are reasonable and appropriate, different assumptions and estimates could materially impact its reported financial results. In addition, sustained declines in the Company’s stock price and related market capitalization could impact key assumptions in the overall estimated fair values of its reporting units and could result in non-cash impairment charges that could be material to the Company’s consolidated balance sheet or results of operations. Should the carrying value of a reporting unit be in excess of the estimated fair value of that reporting unit, an impairment charge will be recorded to reduce the reporting unit to fair value. The Company also evaluates qualitative factors to determine whether impairment indicators exist for its indefinite-lived intangibles and performs quantitative tests if required. These tests can include the relief from royalty model or other valuation models. The significant assumptions used in the relief from royalty model are future net sales for the related brands, royalty rates and the cost of capital to determine the fair value of the indefinite-lived intangibles. The Company completed the quantitative impairment analysis for its indefinite-lived assets as of October 1, 2023, by comparing the fair value of the indefinite-lived trade names to their respective carrying value using a relief from royalty method. As of October 1, 2023, the fair value of the Company’s indefinite-lived trade names exceeded their respective carrying values by 7%. While the indefinite-lived trade name was not determined to be impaired, if the indefinite-lived trade name does not perform as projected or if market factors utilized in the impairment analysis deteriorate, including an unfavorable change in the weighted average cost of capital, could materially affect the expected cash flows, and such impacts could potentially result in a material non-cash impairment charge. Long-lived assets, including intangible assets deemed to have finite lives, are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Impairment indicators include, among other conditions, cash flow deficits, historic or anticipated declines in revenue or operating profit or material adverse changes in the business climate that indicate that the carrying amount of an asset may be impaired. When impairment indicators are present, the recoverability of the asset is measured by comparing the carrying value of the asset to the estimated undiscounted future cash flows expected to be generated by the asset. If the carrying amount of the asset is not recoverable, the impairment to be recognized is measured by the amount by which the carrying amount of each long-lived asset exceeds the fair value of the asset. See NOTE 5 — INTANGIBLE ASSETS to the unaudited condensed consolidated financial statements included in this Quarterly Report on Form 10-Q for additional information.
Leases	Leases The Company determines if an arrangement is a lease at the inception of a contract. Operating lease right-of-use (“ROU”) assets are included in operating lease right-of-use assets on the condensed consolidated balance sheets. The current and long-term components of operating lease liabilities are included in the current portion of operating lease liability and operating lease liabilities, respectively, on the condensed consolidated balance sheets. Finance leases are included in property and equipment, net, accrued expenses and other long-term liabilities. The Company’s finance leases are not material to the Company’s condensed consolidated balance sheets. Operating lease ROU assets and operating lease liabilities are recognized based on the present value of the future minimum lease payments over the lease term. As most of the Company’s leases do not provide an implicit rate, the Company uses an incremental borrowing rate based on the information available at the commencement date in determining the present value of future payments. The operating lease ROU asset may also include any lease payments made, adjusted for any prepaid or accrued rent payments, lease incentives, and initial direct costs incurred. Certain leases may include options to extend or terminate the lease. Lease expense for minimum lease payments is recognized on a straight-line basis over the lease term. For certain equipment leases, the Company applies a portfolio approach to effectively account for any ROU assets and lease liabilities. Leases with an initial term of twelve months or less are not recorded on the balance sheet. The Company has elected the practical expedient to account for each separate lease component of a contract and its associated non-lease components as a single lease component, thus causing all fixed payments to be capitalized.
Employee healthcare	Employee healthcare The Company self-insures certain portions of its health insurance plan. The Company maintains an accrual for estimated unpaid claims and claims incurred but not yet reported (“IBNR”). Although management believes that it uses the best information available to estimate IBNR claims, actual claims may vary significantly from estimated claims.
Restructuring Expenses	Restructuring expenses Costs associated with restructuring activities are recorded at fair value when a liability has been incurred. Generally, a liability has been incurred at the communication date for severance. Charges associated with lease terminations, related to restructuring activities, are recognized at the effective date of the lease modification. During the three months ended March 31, 2023, the Company incurred $0.8 million of unallocated corporate expense related to the termination payment with its former Executive Chairman, Jeffrey Siegel (the “Executive Chairman”). On November 1, 2022, the Company entered into a transition agreement with its Executive Chairman which terminated his employment with the Company, effective March 31, 2023. The employment agreement provided for a one-time payment, which was paid on April 7, 2023.
New accounting pronouncements	New accounting pronouncements Updates not listed below were assessed and either determined to not be applicable or are expected to have a minimal effect on the Company’s financial position, results of operations, and disclosures. In November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures: which enhances the disclosures required for operating segments in the Company’s annual and interim consolidated financial statements. The new guidance is effective for public business entities for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024 on a retrospective basis. Early adoption is permitted. Management is currently evaluating the impact of this standard on its consolidated financial statements and related disclosures. In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures: This guidance is intended to enhance the transparency and decision usefulness of income tax disclosures. The amendments in ASU 2023-09 address investor requests for enhanced income tax information primarily through changes to the rate reconciliation and income taxes paid information. Early adoption is permitted. The new guidance is effective for public business entities for annual periods beginning after December 15, 2024 on a prospective basis. Retrospective application is permitted. Management is currently evaluating the impact of this standard on its consolidated financial statements and related disclosures.

BASIS OF PRESENTATION AND SUMMARY OF ACCOUNTING POLICIES (Tables)

3 Months Ended

Mar. 31, 2024

Accounting Policies [Abstract]

Components of Inventory

The components of inventory were as follows (in thousands):


	March 31, 2024		December 31, 2023
Finished goods	$	181,627	$	180,860
Work in process	164		106
Raw materials	8,029		7,681
Total	$	189,820	$	188,647

REVENUE (Tables)

3 Months Ended

Mar. 31, 2024

Revenue from Contract with Customer [Abstract]

Disaggregation of Revenue

The following tables present the Company’s net sales disaggregated by segment, product category and geographic region for the three months ended March 31, 2024 and 2023 (in thousands):


	Three Months Ended
	March 31,
	2024		2023
U.S. segment
Kitchenware	$	83,530	$	85,732
Tableware	25,759		23,999
Home Solutions	21,191		23,754
Total U.S. segment	130,480		133,485



International segment	11,762		11,950
Total net sales	$	142,242	$	145,435

United States	$	120,503	$	127,246
United Kingdom	7,466		8,612
Rest of World	14,273		9,577
Total net sales	$	142,242	$	145,435

LEASES (Tables)

3 Months Ended

Mar. 31, 2024

Leases [Abstract]

Lease, Cost

The components of lease expense for the three months ended March 31, 2024 and 2023 were as follows (in thousands):


	Three Months Ended March 31,
	2024		2023
Operating lease expenses(1):
Fixed lease expense	$	4,263	$	4,174
Variable lease expense	1,368		1,426
Total	$	5,631	$	5,600

(1) Expenses are recorded within distribution expenses and selling, general and administrative expenses on the unaudited condensed consolidated statement of operations.

Schedule Of Supplemental Cash Flow Information Related To Leases

Supplemental cash flow information for lease related liabilities and assets for the three months ended March 31, 2024 and 2023 were as follows (in thousands):


	Three Months Ended March 31,
	2024		2023
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows for operating leases	$	4,718	$	4,887


	Three Months Ended March 31,
	2024		2023
Right-of-use assets obtained in exchange for lease obligations:
Operating leases	$	—	$	1,184

Lessee, Operating Lease, Liability, Maturity

The aggregate future lease payments for operating leases as of March 31, 2024 were as follows (in thousands):


	Operating
2024 (excluding the three months ended March 31, 2024)	$	14,231
2025	18,721
2026	18,348
2027	14,219
2028	12,824
2029	6,678
Thereafter	11,749
Total lease payments	96,770
Less: Interest	(16,241)
Present value of lease payments	$	80,529

Schedule Of Average Lease Terms And Discount Rates

Average lease terms and discount rates were as follows:


	March 31, 2024
Operating leases:
Weighted-average remaining lease term (years)	5.7
Weighted-average discount rate	6.4	%

INVESTMENTS (Tables)

3 Months Ended

Mar. 31, 2024

Equity Method Investments and Joint Ventures [Abstract]

Summarized Equity in Earnings, Net of Taxes [Table]


	Three Months Ended March 31,
	2024		2023
Vasconia equity in losses, net of taxes	$	(2,092)	$	(724)
Impairment on investment in Vasconia	—		(2,053)
Equity in losses, net of taxes	$	(2,092)	$	(2,777)

INTANGIBLE ASSETS (Tables)

3 Months Ended

Mar. 31, 2024

Goodwill and Intangible Assets Disclosure [Abstract]

Schedule of Intangible Assets and Goodwill [Table Text Block]

Intangible assets consisted of the following as of March 31, 2024 and December 31, 2023 (in thousands):


	March 31, 2024				December 31, 2023
	Gross		Accumulated Amortization		Net		Gross		Accumulated Amortization		Net
Goodwill(1)	$	33,237	$	—	$	33,237	$	33,237	$	—	$	33,237
Indefinite-lived intangible assets:
Trade names(1)	42,000		—		42,000		42,000		—		42,000
Finite-lived intangible assets:
Licenses	15,847		(12,224)		3,623		15,847		(12,110)		3,737
Trade names(2)	62,475		(24,896)		37,579		62,493		(23,862)		38,631
Customer relationships(2)	143,157		(66,124)		77,033		143,158		(63,630)		79,528
Other (2)	5,870		(3,999)		1,871		5,872		(3,872)		2,000
Total	$	302,586	$	(107,243)	$	195,343	$	302,607	$	(103,474)	$	199,133

DEBT (Tables)

3 Months Ended

Mar. 31, 2024

Debt Disclosure [Abstract]

Schedule of Line of Credit Facilities

As of March 31, 2024 and December 31, 2023, the total availability under the ABL Agreement were as follows (in thousands):


	March 31, 2024		December 31, 2023
Maximum aggregate principal allowed	$	146,084	$	181,919
Outstanding borrowings under the ABL Agreement	(40,860)		(60,395)
Standby letters of credit	(8,522)		(2,894)
Total availability under the ABL Agreement	$	96,702	$	118,630

Schedule of Long-term Debt Instruments

The current and non-current portions of the Company’s Term Loan included in the condensed consolidated balance sheets were as follows (in thousands):


	March 31, 2024		December 31, 2023
Current portion of Term Loan:
Term Loan payment	$	9,375	$	7,500
Estimated Excess Cash Flow principal payment	4,000		—
Estimated unamortized debt issuance costs	(2,723)		(2,758)
Total Current portion of Term Loan	$	10,652	$	4,742

Non-current portion of Term Loan:
Term Loan, net of current portion	$	136,625	$	142,500
Estimated unamortized debt issuance costs	(5,999)		(6,666)
Total Non-current portion of Term Loan	$	130,626	$	135,834

DERIVATIVES (Tables)

3 Months Ended

Mar. 31, 2024

Derivative Instruments and Hedging Activities Disclosure [Abstract]

Fair Values of Derivative Financial Instruments Included in Unaudited Condensed Consolidated Balance Sheets

The fair values of the Company’s derivative financial instruments included in the condensed consolidated balance sheets are presented as follows (in thousands):


Derivatives designated as hedging instruments	Balance Sheet Location	March 31, 2024		December 31, 2023




Foreign exchange contracts	Prepaid expenses and other current assets	$	67	$	56

	Accrued expenses	73		144


Derivatives not designated as hedging instruments	Balance Sheet Location	March 31, 2024		December 31, 2023
Interest rate swaps	Prepaid expenses and other current assets	$	722	$	—
	Other assets	—		793
	Other long-term liabilities	104		—

Gains and Losses Related to Derivative Financial Instruments Designated as Hedging Instruments


	Three Months Ended March 31,
Derivatives designated as hedging instruments	2024		2023
Interest rate swaps	$	—	$	(120)
Foreign exchange contracts	201		(1,033)
	$	201	$	(1,153)

Derivatives Not Designated as Hedging Instruments

Interest and mark to market (losses) related to the Company’s derivative financial instruments not designated as hedging instruments that were recognized in earnings are as follows (in thousands):


		Three Months Ended March 31,
Derivatives not designated as hedging instruments	Location of gain (loss)	2024		2023
Interest rate swaps	Mark to market (loss) on interest rate derivatives	$	(174)	$	(234)
	Interest expense	221		165
		$	47	$	(69)

STOCK COMPENSATION (Tables)

3 Months Ended

Mar. 31, 2024

Share-Based Payment Arrangement [Abstract]

Summary of Stock Option Activity and Related Information

A summary of the Company’s stock option activity and related information for the three months ended March 31, 2024 is as follows:


	Options		Weighted- average exercise price		Weighted- average remaining contractual life (years)	Aggregate intrinsic value (in thousands)
Options outstanding, January 1, 2024	999,500		$	13.31
Grants	50,000		9.76


Expirations	(100,000)		18.04
Options outstanding, March 31, 2024	949,500		12.63		4.6	$	742
Options exercisable, March 31, 2024	806,875		$	13.21	3.8	$	506
Total unrecognized stock option expense remaining (in thousands)	$	556
Weighted-average years expected to be recognized over	1.9

Summary of Restricted Stock Activity

A summary of the Company’s restricted stock activity and related information for the three months ended March 31, 2024 is as follows:


	Restricted Shares		Weighted- average grant date fair value
Non-vested restricted shares, January 1, 2024	597,528		$	8.44
Grants	219,975		9.76
Vested	(140,060)		10.67
Cancellations	(6,814)		10.39
Non-vested restricted shares, March 31, 2024	670,629		$	8.38
Total unrecognized compensation expense remaining (in thousands)	$	4,857
Weighted-average years expected to be recognized over	1.9

Summary of Performance-based Award Activity

A summary of the Company’s performance-based award activity and related information for the three months ended March 31, 2024 is as follows:


	Performance- based stock awards (1)		Weighted- average grant date fair value
Non-vested performance-based awards, January 1, 2024	486,972		$	10.44
Grants	219,975		9.76

Vested	(152,188)		14.18
Cancellations	(23,047)		13.54
Non-vested performance-based awards, March 31, 2024	531,712		$	8.96
Total unrecognized compensation expense remaining (in thousands)(2)	$	2,720
Weighted-average years expected to be recognized over	2.5

(1)Represents the target number of shares to be issued for each performance-based award.

(2)The performance metric for the performance-based awards granted in 2022 is not probable of achievement. Therefore, no compensation expense has been recorded on these awards.

Share-based Payment Arrangement, Cash Settled Performance Shares, Activity [Table Text Block]

A summary of the Company’s cash-settled performance-based awards activity and related information for the three months ended March 31, 2024 is as follows:


	Cash-settled performance-based awards (1)		Weighted- average fair value
Non-vested cash-settled performance-based awards, January 1, 2024	83,611		$	6.71


Cancellations	(1,107)		10.14
Non-vested cash-settled performance-based awards, March 31, 2024	82,504		$	10.48
Total unrecognized compensation expense remaining (in thousands)(2)	$	—
Weighted-average years expected to be recognized over	0.0

(1) Represents the target number of units to be settled in cash.

(2) The performance metric for the cash-settled performance-based awards granted in 2022 is not probable of achievement. Therefore, no compensation expense has been recorded on these awards.

Summary of Stock Compensation Expense

The Company recorded stock compensation expense as follows (in thousands):


	Three Months Ended March 31,
Stock Compensation Expense Components	2024		2023
Equity based stock option expense	$	50	$	129
Restricted and performance-based stock awards expense	749		737
Stock compensation expense for equity based awards	$	799	$	866
Liability based stock option expense	8		(5)

Total Stock Compensation Expense	$	807	$	861

INCOME (LOSS) PER COMMON SHARE (Tables)

3 Months Ended

Mar. 31, 2024

Earnings Per Share [Abstract]

Calculations of Basic and Diluted Income (Loss) per Common Share

The calculations of basic and diluted loss per common share for the three months ended March 31, 2024 and 2023 are as follows:


	Three Months Ended March 31,
	2024		2023
	(in thousands, except per share amounts)
Net loss – Basic and Diluted	$	(6,260)	$	(8,805)
Weighted-average shares outstanding – Basic	21,377		21,225
Effect of dilutive securities:
Stock options and other stock awards	—		—
Weighted-average shares outstanding – Diluted	21,377		21,225
Basic loss per common share	$	(0.29)	$	(0.41)
Diluted loss per common share	$	(0.29)	$	(0.41)
Antidilutive Securities(1)	1,605		1,581

(1) Stock options and other stock awards that have been excluded from the denominator as their inclusion would have been anti-dilutive.

BUSINESS SEGMENTS (Tables)

3 Months Ended

Mar. 31, 2024

Segment Reporting [Abstract]

Segment Reporting Information


	Three Months Ended March 31,
	2024		2023
	(in thousands)
Net sales
U.S.	$	130,480	$	133,485
International	11,762		11,950
Total net sales	$	142,242	$	145,435
Income (loss) from operations
U.S.	$	9,442	$	5,954
International	(3,089)		(1,892)
Unallocated corporate expenses	(4,523)		(5,868)
Income (loss) from operations	$	1,830	$	(1,806)
Depreciation and amortization
U.S.	$	4,656	$	4,618
International	283		252
Total depreciation and amortization	$	4,939	$	4,870


	March 31, 2024		December 31, 2023
	(in thousands)
Assets
U.S.	$	518,377	$	560,716
International	79,650		90,237
Unallocated corporate	4,639		16,189
Total Assets	$	602,666	$	667,142

OTHER (Tables)

3 Months Ended

Mar. 31, 2024

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Cash Dividends Declared

Dividends declared in the three months ended March 31, 2024 were as follows:

Dividend per share

Date declared

Date of record

Payment date

$0.0425

3/8/2024

5/1/2024

5/15/2024

Supplemental Cash Flow Information

Supplemental cash flow information


	Three Months Ended March 31,
	2024		2023
	(in thousands)
Supplemental disclosure of cash flow information:
Cash paid for interest	$	5,105	$	5,104
Cash paid for taxes, net of refunds	282		320

Components of Accumulated Other Comprehensive Loss, Net

Components of accumulated other comprehensive loss, net


	Three Months Ended March 31,
	2024		2023
	(in thousands)
Accumulated translation adjustment:
Balance at beginning of period	$	(32,614)	$	(36,072)
Translation adjustment during period	40		1,561


Balance at end of period	$	(32,574)	$	(34,511)
Accumulated deferred gains (losses) on cash flow hedges:
Balance at beginning of period	$	(134)	$	923
Change in unrealized gains (losses)	70		(250)
Amounts reclassified from accumulated other comprehensive loss:
Settlement of cash flow hedge (1)	131		(903)
Net change in cash flow hedges, net of taxes of $0, $(2)	201		(1,153)
Balance at end of period	$	67	$	(230)
Accumulated effect of retirement benefit obligations:
Balance at beginning of period	$	(751)	$	(705)
Amounts reclassified from accumulated other comprehensive loss: (2)
Amortization of actuarial loss, net of taxes of $(4), $(4)	13		12
Balance at end of period	$	(738)	$	(693)
Total accumulated other comprehensive loss at end of period	$	(33,245)	$	(35,434)

(1)Amounts reclassified are recorded in interest expense and cost of sales on the unaudited condensed consolidated statement of operations.

(2)Amounts are recorded in selling, general and administrative expense on the unaudited condensed consolidated statements of operations.

BASIS OF PRESENTATION AND SUMMARY OF ACCOUNTING POLICIES - Additional Information (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Mar. 31, 2024	Mar. 31, 2023	Dec. 31, 2023	Dec. 31, 2022
Schedule Of Significant Accounting Policies [Line Items]
Percentage of total annual net sales in the third and fourth quarters			57.00%	54.00%
Restructuring expenses	$ 0	$ 856
Trade names(1)
Schedule Of Significant Accounting Policies [Line Items]
Goodwill, percentage of fair value in excess of carrying value	7.00%
U.S.
Schedule Of Significant Accounting Policies [Line Items]
Goodwill, percentage of fair value in excess of carrying value	4.00%
Unallocated [Member] \| Employee Severance
Schedule Of Significant Accounting Policies [Line Items]
Restructuring expenses		$ 800
Receivables Purchase Agreement
Schedule Of Significant Accounting Policies [Line Items]
Receivables available for sale	$ 23,800

BASIS OF PRESENTATION AND SUMMARY OF ACCOUNTING POLICIES - Components of Inventory (Details) - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Accounting Policies [Abstract]
Finished goods	$ 181,627	$ 180,860
Work in process	164	106
Raw materials	8,029	7,681
Total	$ 189,820	$ 188,647

REVENUE - Additional Information (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Disaggregation of Revenue [Line Items]
Net sales	$ 142,242	$ 145,435
Shipping and Handling
Disaggregation of Revenue [Line Items]
Net sales	$ 600	$ 500

REVENUE - Summary of Company's Revenue Disaggregated by Geographic Region and Revenue (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Disaggregation of Revenue [Line Items]
Net sales	$ 142,242	$ 145,435
United States
Disaggregation of Revenue [Line Items]
Net sales	120,503	127,246
United Kingdom
Disaggregation of Revenue [Line Items]
Net sales	7,466	8,612
Rest of World
Disaggregation of Revenue [Line Items]
Net sales	14,273	9,577
U.S. segment
Disaggregation of Revenue [Line Items]
Net sales	130,480	133,485
U.S. segment \| Kitchenware
Disaggregation of Revenue [Line Items]
Net sales	83,530	85,732
U.S. segment \| Tableware
Disaggregation of Revenue [Line Items]
Net sales	25,759	23,999
U.S. segment \| Home Solutions
Disaggregation of Revenue [Line Items]
Net sales	21,191	23,754
International segment
Disaggregation of Revenue [Line Items]
Net sales	$ 11,762	$ 11,950

LEASES - Lease Cost (Details) - USD ($) $ in Thousands	3 Months Ended
LEASES - Lease Cost (Details) - USD ($) $ in Thousands	Mar. 31, 2024	Mar. 31, 2023
Operating lease expenses:
Fixed lease expense	$ 4,263	$ 4,174
Variable lease expense	1,368	1,426
Total	$ 5,631	$ 5,600

LEASES - Supplemental Cash Flow Information Related To Leases (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows for operating leases	$ 4,718	$ 4,887
Right-of-use assets obtained in exchange for lease obligations:
Operating leases	$ 0	$ 1,184

LEASES - Maturities of Operating Lease Liability (Details) $ in Thousands	Mar. 31, 2024 USD ($)
Leases [Abstract]
2024 (excluding the three months ended March 31, 2024)	$ 14,231
2025	18,721
2026	18,348
2027	14,219
2028	12,824
2029	6,678
Thereafter	11,749
Total lease payments	96,770
Less: Interest	(16,241)
Present value of lease payments	$ 80,529

LEASES - Average Lease Terms And Discount Rates (Details)	Mar. 31, 2024
Leases [Abstract]
Operating lease, weighted average remaining lease term (in years)	5 years 8 months 12 days
Operating lease, weighted average discount rate, percent	6.40%

INVESTMENTS - Additional Information (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023	Dec. 31, 2023
Schedule of Equity Method Investments [Line Items]
Income (Loss) from Equity Method Investments	$ 2,092	$ 2,777
Accumulated other comprehensive loss	$ (33,245)		$ (33,499)
Grupo Vasconia S.A.B.
Schedule of Equity Method Investments [Line Items]
Percentage of ownership in equity method investment	24.70%
Increase (decrease) in equity method investment	$ 300	700
Income (Loss) from Equity Method Investments	2,092	724
Equity Investment Impairment Charge	0	$ (2,053)
Carrying value of investment	0		$ 1,800
Accumulated other comprehensive loss	$ 14,200

INVESTMENTS - Summarized Equity in Earnings, Net of Taxes (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Schedule of Equity Method Investments [Line Items]
Equity in losses, net of taxes	$ (2,092)	$ (2,777)
Grupo Vasconia S.A.B.
Schedule of Equity Method Investments [Line Items]
Equity in losses, net of taxes	(2,092)	(724)
Equity Investment Impairment Charge	$ 0	$ (2,053)

INTANGIBLE ASSETS - Components of Intangible Assets (Details) - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Schedule of Intangible Assets Disclosure [Line Items]
Goodwill, Gross	$ 33,237	$ 33,237
Goodwill	33,237	33,237
Finite-lived intangible assets, Accumulated Amortization	(107,243)	(103,474)
Total, Gross	302,586	302,607
Total, Net	195,343	199,133
Goodwill, Impaired, Accumulated Impairment Loss	(91,700)
Indefinite-lived Intangible Assets, impaired, accumulated impairment loss,	1,000
Finite-lived Intangible Assets Reduction of Impairment, Gross	44,100
Finite-lived Intangible Assets reduction for Impairment, Accumulated Amortization	(29,300)
Accumulated Impairment Of Intangible Assets, Finite Lived	(14,800)
Finite-lived Intangible Assets Reduction for Impairment of U.S. Segment, Gross	6,500
Licenses
Schedule of Intangible Assets Disclosure [Line Items]
Finite-lived intangible assets, Gross	15,847	15,847
Finite-lived intangible assets, Accumulated Amortization	(12,224)	(12,110)
Finite-lived intangible assets, Net	3,623	3,737
Trade names(1)
Schedule of Intangible Assets Disclosure [Line Items]
Finite-lived intangible assets, Gross	62,475	62,493
Finite-lived intangible assets, Accumulated Amortization	(24,896)	(23,862)
Finite-lived intangible assets, Net	37,579	38,631
Customer relationships(2)
Schedule of Intangible Assets Disclosure [Line Items]
Finite-lived intangible assets, Gross	143,157	143,158
Finite-lived intangible assets, Accumulated Amortization	(66,124)	(63,630)
Finite-lived intangible assets, Net	77,033	79,528
Other (2)
Schedule of Intangible Assets Disclosure [Line Items]
Finite-lived intangible assets, Gross	5,870	5,872
Finite-lived intangible assets, Accumulated Amortization	(3,999)	(3,872)
Finite-lived intangible assets, Net	1,871	2,000
Trade names(1)
Schedule of Intangible Assets Disclosure [Line Items]
Indefinite-lived intangible assets, Gross	42,000	42,000
Indefinite-lived intangible assets, Net	$ 42,000	$ 42,000

DEBT - Additional Information (Details) - USD ($)	3 Months Ended
DEBT - Additional Information (Details) - USD ($)	Mar. 31, 2024	Dec. 31, 2023
Debt Instrument [Line Items]
Quarterly payments, percentage of principal amount	1.25%
Maximum debt instrument leverage ratio	3.25
Extended Term Loan [Member]
Debt Instrument [Line Items]
Debt instrument, face amount	$ 150,000,000
ABL Credit Agreement
Debt Instrument [Line Items]
Maximum aggregate principal allowed	146,084,000	$ 181,919,000
Minimum availability under revolving credit to maintain minimum fixed charge ratio for four consecutive months	$ 20,000,000
Commitment fee percentage	10.00%
Maximum fixed charge coverage ratio	1.10
Debt Agreements
Debt Instrument [Line Items]
Percentage of capital stock of foreign subsidiaries pledged as collateral	65.00%
Minimum term under revolving credit to maintain minimum fixed charge ratio	45 days
Term Loan
Debt Instrument [Line Items]
Debt Instrument, Covenant, Maximum Total Net Leverage Ratio	5.00
Interest rates on outstanding borrowings	10.94%
Term Loan \| Federal Funds And Overnight Bank Funding Based Rate
Debt Instrument [Line Items]
Basis spread on variable rate	0.50%
Term Loan \| Alternate Base Rate
Debt Instrument [Line Items]
Basis spread on variable rate	4.50%
Term Loan \| One Month Adjusted Term SEcured Overnight Financing Rate ("SOFR")
Debt Instrument [Line Items]
Basis spread on variable rate	1.00%
Term Loan \| SOFR
Debt Instrument [Line Items]
Basis spread on variable rate	5.50%
Minimum \| Term Loan \| One Month Adjusted Term SEcured Overnight Financing Rate ("SOFR")
Debt Instrument [Line Items]
Debt instrument, stated rate	1.00%
Minimum \| Term Loan \| SOFR
Debt Instrument [Line Items]
Debt instrument, stated rate	1.00%
Senior Secured Asset Based Revolving Credit Facilities \| ABL Credit Agreement
Debt Instrument [Line Items]
Maximum aggregate principal allowed	$ 200,000,000
Increase in maximum borrowing capacity	250,000,000
Debt instrument, stated amount	$ 50,000,000
Revolving Credit Facility \| ABL Credit Agreement
Debt Instrument [Line Items]
Line of Credit Facility, Unused Capacity, Commitment Fee Percentage Paid	0.25%
Revolving Credit Facility \| ABL Credit Agreement \| Federal Funds And Overnight Bank Funding Based Rate
Debt Instrument [Line Items]
Basis spread on variable rate	0.50%
Revolving Credit Facility \| ABL Credit Agreement \| One Month Adjusted Term SEcured Overnight Financing Rate ("SOFR")
Debt Instrument [Line Items]
Debt instrument, stated rate	1.00%
Revolving Credit Facility \| ABL Credit Agreement \| 1, 3 or 6 month interest period
Debt Instrument [Line Items]
Debt instrument, stated rate	0.10%
Revolving Credit Facility \| Minimum \| ABL Credit Agreement
Debt Instrument [Line Items]
Commitment fee percentage	0.20%
Revolving Credit Facility \| Minimum \| ABL Credit Agreement \| Alternate Base Rate
Debt Instrument [Line Items]
Basis spread on variable rate	0.25%
Revolving Credit Facility \| Minimum \| ABL Credit Agreement \| One Month Adjusted Term SEcured Overnight Financing Rate ("SOFR")
Debt Instrument [Line Items]
Debt instrument, stated rate	1.00%
Revolving Credit Facility \| Minimum \| ABL Credit Agreement \| Adjusted Term SOFR
Debt Instrument [Line Items]
Basis spread on variable rate	1.25%
Revolving Credit Facility \| Minimum \| ABL Credit Agreement \| SOFR
Debt Instrument [Line Items]
Interest rates on outstanding borrowings	6.44%
Revolving Credit Facility \| Maximum \| ABL Credit Agreement
Debt Instrument [Line Items]
Commitment fee percentage	0.25%
Revolving Credit Facility \| Maximum \| ABL Credit Agreement \| Alternate Base Rate
Debt Instrument [Line Items]
Basis spread on variable rate	0.50%
Revolving Credit Facility \| Maximum \| ABL Credit Agreement \| Adjusted Term SOFR
Debt Instrument [Line Items]
Basis spread on variable rate	1.50%
Revolving Credit Facility \| Maximum \| ABL Credit Agreement \| SOFR
Debt Instrument [Line Items]
Interest rates on outstanding borrowings	8.75%

DEBT - Total Availability Under ABL Agreement (Details) - ABL Credit Agreement - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Debt Instrument [Line Items]
Maximum aggregate principal allowed	$ 146,084	$ 181,919
Line of Credit, Current	(40,860)	(60,395)
Standby letters of credit	(8,522)	(2,894)
Total availability under the ABL Agreement	$ 96,702	$ 118,630

DEBT - Schedule of Term Loan Facility (Details) - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Debt Instrument [Line Items]
Total Current portion of Term Loan facility	$ 10,652	$ 4,742
Term Loan
Debt Instrument [Line Items]
Term Loan payment	9,375	7,500
Estimated Excess Cash Flow principal payment	4,000	0
Estimated unamortized debt issuance costs	(2,723)	(2,758)
Total Current portion of Term Loan facility	10,652	4,742
Total Non Current portion of Term Loan facility	136,625	142,500
Estimated unamortized debt issuance costs	(5,999)	(6,666)
Total Non-current portion of Term Loan	$ 130,626	$ 135,834

DERIVATIVES - Additional Information (Details) - USD ($)	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023	Jun. 30, 2019
Derivative [Line Items]
Gain (loss) reclassified into earnings	$ (100,000)	$ 900,000
Loss to be reclassified within 12 months	100,000
Interest rate swaps
Derivative [Line Items]
Notional amount	50,000,000	25,000,000
Derivatives designated as hedging instruments \| Foreign exchange contracts
Derivative [Line Items]
Notional amount	7,000,000
Derivatives designated as hedging instruments \| Cash Flow Hedging \| Interest rate swaps
Derivative [Line Items]
Notional amount	0
Derivatives not designated as hedging instruments \| Interest rate swaps
Derivative [Line Items]
Notional amount	$ 25,000,000		$ 25,000,000
Interest expense \| Interest rate swaps
Derivative [Line Items]
Gain (loss) reclassified into earnings		100,000
Cost of Sales \| Foreign exchange contracts
Derivative [Line Items]
Gain (loss) reclassified into earnings		$ 800,000

DERIVATIVES - Fair Values of Derivative Financial Instruments Included in Consolidated Balance Sheets (Details) - Fair Value, Observable inputs, Level 2 - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Prepaid expenses and other current assets \| Foreign exchange contracts \| Derivatives designated as hedging instruments
Derivatives, Fair Value [Line Items]
Fair value of derivative assets	$ 67	$ 56
Prepaid expenses and other current assets \| Interest rate swaps \| Derivatives not designated as hedging instruments
Derivatives, Fair Value [Line Items]
Fair value of derivative assets	722
Accrued expenses \| Foreign exchange contracts \| Derivatives designated as hedging instruments
Derivatives, Fair Value [Line Items]
Fair value of derivative assets	73	144
Other Noncurrent Assets \| Interest rate swaps \| Derivatives not designated as hedging instruments
Derivatives, Fair Value [Line Items]
Fair value of derivative assets	0	793
Other long-term liabilities \| Interest rate swaps \| Derivatives not designated as hedging instruments
Derivatives, Fair Value [Line Items]
Fair value of derivative liability	$ 104	$ 0

DERIVATIVES - Gains and Losses Related to Derivative Financial Instruments Designated as Hedging Instruments (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Derivative Instruments, Gain (Loss) [Line Items]
Net change in cash flow hedges	$ 201	$ (1,153)
Interest rate swaps
Derivative Instruments, Gain (Loss) [Line Items]
Net change in cash flow hedges	0	(120)
Foreign exchange contracts
Derivative Instruments, Gain (Loss) [Line Items]
Net change in cash flow hedges	$ 201	$ (1,033)

DERIVATIVES - Gains and Losses Related to Derivative Financial Instruments Not Designated as Hedging Instruments (Details) - Interest rate swaps - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Derivative Instruments, Gain (Loss) [Line Items]
Gains (losses) on derivative financial instruments not designated as hedging instruments	$ 47	$ (69)
Mark to market (loss) on interest rate derivatives
Derivative Instruments, Gain (Loss) [Line Items]
Gains (losses) on derivative financial instruments not designated as hedging instruments	(174)	(234)
Interest expense
Derivative Instruments, Gain (Loss) [Line Items]
Gains (losses) on derivative financial instruments not designated as hedging instruments	$ 221	$ 165

STOCK COMPENSATION - Summary of Stock Option (Details) $ / shares in Units, $ in Thousands	3 Months Ended
	Mar. 31, 2024 USD ($) $ / shares shares
Options
Beginning balance (in shares) \| shares	999,500
Grants (in shares) \| shares	50,000
Expirations (in shares) \| shares	(100,000)
Ending balance (in shares) \| shares	949,500
Options exercisable, end of period (in shares) \| shares	806,875
Weighted- average exercise price
Beginning balance (usd per share) \| $ / shares	$ 13.31
Grants (usd per share) \| $ / shares	9.76
Expirations (usd per share) \| $ / shares	18.04
Ending balance (usd per share) \| $ / shares	12.63
Weighted-average exercise price, Options exercisable, end of period (usd per share) \| $ / shares	$ 13.21
Weighted- average remaining contractual life (years)
Options outstanding, end of period	4 years 7 months 6 days
Options exercisable, end of period	3 years 9 months 18 days
Aggregate intrinsic value (in thousands)
Options outstanding, aggregate intrinsic Value \| $	$ 742
Options exercisable, aggregate intrinsic Value \| $	506
Total unrecognized stock option expense remaining (in thousands) \| $	$ 556
Weighted-average years expected to be recognized over (in years)	1 year 10 months 24 days

STOCK COMPENSATION - Summary of Restricted Stock Activity (Details) $ / shares in Units, $ in Thousands	3 Months Ended
	Mar. 31, 2024 USD ($) $ / shares shares
Restricted Shares
Weighted-average years expected to be recognized over (in years)	1 year 10 months 24 days
Restricted Stock
Restricted Shares
Beginning balance (in shares) \| shares	597,528
Grants (in shares) \| shares	219,975
Vested (in shares) \| shares	(140,060)
Cancellations (in shares) \| shares	(6,814)
Ending balance (in shares) \| shares	670,629
Total unrecognized compensation expense remaining (in thousands) \| $	$ 4,857
Weighted-average years expected to be recognized over (in years)	1 year 10 months 24 days
Weighted- average grant date fair value
Beginning balance (usd per share) \| $ / shares	$ 8.44
Grants (usd per share) \| $ / shares	9.76
Vested (usd per share) \| $ / shares	10.67
Cancellations (usd per share) \| $ / shares	10.39
Ending balance (usd per share) \| $ / shares	$ 8.38

STOCK COMPENSATION - Additional Information (Details) $ in Millions	3 Months Ended
	Mar. 31, 2024 USD ($) shares
Restricted Stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Fair value of equity instruments	$ 1.4
Performance Shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Fair value of equity instruments	$ 1.5
Number of shares range percentage	150.00%
Performance Shares \| Amended and Restated Long Term Incentive Plan Two Thousand
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares available for grant (in shares) \| shares	242,448
Cash Settled Performance Based Awards
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares range percentage	150.00%

STOCK COMPENSATION - Summary of Performance-based Award Activity (Details) $ / shares in Units, $ in Thousands	3 Months Ended
	Mar. 31, 2024 USD ($) $ / shares shares
Restricted Shares
Weighted-average years expected to be recognized over (in years)	1 year 10 months 24 days
Performance Shares
Restricted Shares
Beginning balance (in shares) \| shares	486,972
Grants (in shares) \| shares	219,975
Vested (in shares) \| shares	(152,188)
Cancellations (in shares) \| shares	(23,047)
Ending balance (in shares) \| shares	531,712
Total unrecognized compensation expense remaining (in thousands) \| $	$ 2,720
Weighted-average years expected to be recognized over (in years)	2 years 6 months
Weighted- average grant date fair value
Beginning balance (usd per share) \| $ / shares	$ 10.44
Grants (usd per share) \| $ / shares	9.76
Vested (usd per share) \| $ / shares	14.18
Cancellations (usd per share) \| $ / shares	13.54
Ending balance (usd per share) \| $ / shares	$ 8.96

STOCK COMPENSATION - Stock Compensation Expense (Details) - USD ($) $ in Thousands		3 Months Ended
	Mar. 08, 2023	Mar. 31, 2024	Mar. 31, 2023
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Stock compensation expense		$ 807	$ 861
Equity based stock option expense
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Stock compensation expense	$ 100	50	129
Restricted and performance-based stock awards expense
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Stock compensation expense		749	737
Equity based awards
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Stock compensation expense		799	866
Liability based stock option expense
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Stock compensation expense		$ 8	$ (5)

STOCK COMPENSATION (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended
	Mar. 31, 2024	Dec. 31, 2023
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Weighted-average years expected to be recognized over (in years)	1 year 10 months 24 days
Cash Settled Performance Based Awards
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Liability Instruments Other Than Options, Forfeited in Period	(1,107)
Share-based Compensation Arrangement by Share-based Payment Award, Liability Instruments Other than Options, Forfeiteds in Period, Weighted Average Grant Date Fair Value	$ 10.14
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number	82,504	83,611
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value	$ 10.48	$ 6.71
Total unrecognized compensation expense remaining (in thousands)	$ 0
Weighted-average years expected to be recognized over (in years)	0 years
Performance Shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total unrecognized compensation expense remaining (in thousands)	$ 2,720
Weighted-average years expected to be recognized over (in years)	2 years 6 months

INCOME (LOSS) PER COMMON SHARE - Calculations of Basic and Diluted Loss per Common Share (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Line Items]
Net loss	$ (6,260)	$ (8,805)
Weighted-average shares outstanding - Basic (in shares)	21,377	21,225
Effect of dilutive securities:
Weighted-average shares outstanding - diluted (in shares)	21,377	21,225
Basic income (loss) per common share (usd per share)	$ (0.29)	$ (0.41)
Diluted income (loss) per common share (usd per share)	$ (0.29)	$ (0.41)
Antidilutive securities (in shares)	1,605	1,581
Stock options and other stock awards
Effect of dilutive securities:
Stock options and other stock awards (in shares)	0	0

INCOME TAXES - Additional Information (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Income Tax Disclosure [Abstract]
Income tax (provision) benefit	$ (210)	$ 1,348
Effective income tax benefit rate on US and foreign earnings, percent	(5.30%)	18.30%
Corporate income tax rate	21.00%	21.00%

BUSINESS SEGMENTS - Additional Information (Details)	3 Months Ended
BUSINESS SEGMENTS - Additional Information (Details)	Mar. 31, 2024 segment
Segment Reporting [Abstract]
Number of reportable business segment	2

BUSINESS SEGMENTS - Segment Reporting Information (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023	Dec. 31, 2023
Segment Reporting Information [Line Items]
Net sales	$ 142,242	$ 145,435
Income (loss) from operations	1,830	(1,806)
Depreciation and amortization	4,939	4,870
Assets	602,666		$ 667,142
U.S.
Segment Reporting Information [Line Items]
Net sales	120,503	127,246
Operating segments \| U.S.
Segment Reporting Information [Line Items]
Assets	518,377		560,716
Operating segments \| International
Segment Reporting Information [Line Items]
Assets	79,650		90,237
Unallocated corporate expenses
Segment Reporting Information [Line Items]
Income (loss) from operations	(4,523)	(5,868)
Assets	4,639		$ 16,189
U.S. \| Operating segments
Segment Reporting Information [Line Items]
Net sales	130,480	133,485
Income (loss) from operations	9,442	5,954
Depreciation and amortization	4,656	4,618
International \| Operating segments
Segment Reporting Information [Line Items]
Net sales	11,762	11,950
Income (loss) from operations	(3,089)	(1,892)
Depreciation and amortization	$ 283	$ 252

CONTINGENCIES - Additional Information (Details) $ in Millions		3 Months Ended
	Mar. 31, 2024 USD ($) tablewareCollection	Mar. 31, 2024 USD ($) tablewareCollection	Oct. 15, 2020 protest	Jun. 08, 2020 protest
Commitments and Contingencies Disclosure [Line Items]
Site Contingency, Environmental Remediation Costs Recognized	5.6 million
Number of tableware collections \| tablewareCollection		7
Number of protests filed \| protest				3
Number of remaining tableware collections \| tablewareCollection		29
Number of protests approved \| protest			1
Number of protests pending \| tablewareCollection	2	2
Period of investigation		5 years
Estimated Duties That Could Be Owed
Commitments and Contingencies Disclosure [Line Items]
Reasonable possible loss	$ 0.3	$ 0.3
Negligence
Commitments and Contingencies Disclosure [Line Items]
Reasonable possible loss	0.6	0.6
Gross Negligence
Commitments and Contingencies Disclosure [Line Items]
Reasonable possible loss	$ 1.2	1.2
Capital cost \| San German Ground Water Contamination Site, Initial Operable Unit
Commitments and Contingencies Disclosure [Line Items]
Remedial alternative, EPA preferred remedy		7.3
Capital cost \| San German Ground Water Contamination Site, Second Operable Unit
Commitments and Contingencies Disclosure [Line Items]
Remedial alternative, EPA preferred remedy		$ 17.3

OTHER - Cash Dividends Declared (Details) - USD ($) $ / shares in Units, $ in Millions		3 Months Ended
	Mar. 08, 2024	Mar. 31, 2024	Mar. 31, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Dividend per share of common stock (usd per share)	$ 0.0425	$ 0.0425	$ 0.0425
Cash dividend paid upon vesting of restricted shares and performance shares		$ 0.1

OTHER - Additional Information (Details) - USD ($) $ / shares in Units, $ in Thousands			3 Months Ended
	Mar. 08, 2024	Feb. 15, 2024	Mar. 31, 2024	Mar. 31, 2023	Mar. 14, 2022	Apr. 30, 2013
Other [Line Items]
Cash dividends paid			$ 1,026	$ 985
Dividend per share, declared (usd per share)	$ 0.0425		$ 0.0425	$ 0.0425
Cash dividend paid upon vesting of restricted shares and performance shares			$ 100
Dividends accrued			943	$ 930
Stock Repurchase Program, Authorized Amount					$ 20,000	$ 10,000
Stock Repurchase Program, Remaining Authorized Repurchase Amount			11,100
Retained earnings (accumulated deficit)
Other [Line Items]
Dividends accrued			943	$ 930
Dividend Paid
Other [Line Items]
Cash dividends paid		$ 900	$ 1,000

OTHER - Supplemental Cash Flow Information (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Supplemental disclosure of cash flow information:
Cash paid for interest	$ 5,105	$ 5,104
Cash paid for taxes, net of refunds	$ 282	$ 320